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CHAPTER 1 
Introduction 
“How can we transform to a normal and physiological condition, old age, at present utterly 
pathological, unless we first understand the most intimate details of its mechanism?”  
-Eli Metchnikoff, 1908 
 
 Depression has been identified as a leading threat to overall health and a leading cause of 
disability, and in late life is associated with higher rates of morbidity and mortality (Blazer, 
2003). A subtype of depression believed to be caused by high cerebrovascular burden, termed 
vascular depression, is particularly associated with cognitive decline (Mast, Yochim, MacNeil, & 
Lichtenberg, 2004) and disease of the central nervous system (Sneed, Rindskopf, Steffens, 
Krishnan, & Roose, 2008). Meanwhile, an emerging literature describes frailty as a self-
perpetuating cycle of “multisystemic dysregulation of homeostatic systems,” with numerous risk 
factors and one likely outcome: death (Fried et al., 2001).  Some researchers have noted 
epidemiological and phenomenological similarities between vascular depression and frailty and 
cognitive decline (Katz, 2004), but no cohesive model of relationships between these geriatric 
syndromes has been identified. 
 The objectives of this dissertation are to extend our knowledge of vascular depression by 
evaluating a series of hypotheses based on the concept depicted in Figure 1.1, of cerebrovascular 
burden, depression, frailty, cognitive decline and mortality.  The model that will be evaluated 
conceptualizes these geriatric syndromes as reflecting consecutive phases of a single disease 
process involving global neurological decline. In this model, vascular depression symptoms are 
hypothesized to be a sensitive, early indicator of this disease progression.  
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Depression 
 Major depression occurs in 25% of women and 12% of men across the lifespan and has 
been identified as a major source of disability worldwide (Gelenberg, 2010).  The base rate of the 
disorder varies across the lifespan, decreasing from a peak in early adulthood until the mid-70’s, 
after which symptoms increase with age (Teachman, 2006).  Though a diagnosis of major 
depression is based on whether a patient’s number of symptoms meet a specific threshold 
(American Psychiatric Association, 2000), the number of depression symptoms experienced 
reflects a semi-continuous variable rather than a dichotomous one.  Even modest elevations in 
depression symptoms are associated with higher levels of disability, loss of work, and reduced 
quality of life (Broadhead, Blazer, & George, 1990; Rapaport & Judd, 1998).  Depression 
symptoms are of particular concern among elders, for whom subtle increases relate to impaired 
capacity for self-care (Stuck et al., 1999), deterioration of cognitive faculties (Crocco, Castro, & 
Loewenstein, 2010), and increased mortality risk (Arfken, Lichtenberg, & Tancer, 1999).   
 In clinical settings, depression is identified as the presence of at least one core symptom 
(depressed mood or lack of interest in activities) along with at least four of the following: 
feelings of worthlessness or inappropriate guilt, difficulty concentrating or decision making, 
fatigue, psychomotor agitation or retardation, hypersomnia or insomnia, significant weight loss 
or weight gain, and recurrent death or suicidal ideation (American Psychiatric Association, 
2000). Based on the 8-item CESD used in the Health and Retirement Survey, endorsement of at 
least 3 symptoms corresponds to clinically-significant depression (Steffick, 2000).  The behavior 
that is characteristic of depression can be conceptualized within a broader framework.  Henriques 
proposed that the function of the central nervous system (CNS) is the regulation of behavior as 
described by an economic model (Henriques, 2003).  He further proposed that depression 
represents the conservation of behavioral resources such as caloric energy and social capital 
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(Henriques, 2000).  While depression represents an adaptive mechanism in Henriques’s 
taxonomy, vascular depression differs in this respect.  Vascular depression appears to result from 
the CNS degradation (Sneed et al., 2008), and so this depression subtype should be characterized 
as indicative of a broader disease process.  Nonetheless, it still appears to result in conservation 
of behavioral resources marked by a decrease in social interaction and decline in self-care 
activities.  Because these behavioral outcomes typically do not serve the elder well, vascular 
depression must be viewed as uniformly maladaptive. 
Depression is broadly associated with adverse health outcomes.  Individuals with 
depression have increased risk for stroke (Bos et al., 2008; Larson, Owens, Ford, & W., 2001; 
Salaycik et al., 2007), first heart attack (Glassman & Shapiro, 1998), and cancer (Penninx, 
Guralnik, et al., 1998).  Additionally, depression has been associated with impaired immune 
functioning (Kiecolt-Glaser & Glaser, 2002; Salzet, Vieau, & Day, 2000) and the increase of 
proinflamatory cytokines, IL-6 in particular (Dentino et al., 1999; Lutgendorf et al., 1999; Maes 
et al., 1995; Maes et al., 1999; Maes, Song, Lin, De, & Van, 1998).  Depression is associated 
with increased mortality (Arfken et al., 1999; Covinsky et al., 1999; Mehta et al., 2003), even 
after controlling for cardiovascular risk (Glassman & Shapiro, 1998).  Furthermore, there is 
evidence for an interactive relationship between cognitive functioning and depression. For 
example, older adults with both depressive symptoms and cognitive deficits have a mortality risk 
three times that of their counterparts (Blazer, 2003; Mehta et al., 2003). 
Vascular depression, a depression subtype characteristically observed among older 
adults, is the development of late-onset depression resulting from vascular burden related to such 
factors as diabetes and hypertension.  Alexopoulos et al. (1997) hypothesized a relationship 
between late-onset depression (i.e., first episode of depression after age 65) and cerebrovascular 
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burden and later (1998) proposed that cerebrovascular distress predisposes, precipitates and 
perpetuates symptoms of depression in late life.  The relationship between cerebrovascular 
burden and depression in late life can be described as a threshold effect whereby elders with two 
or more cerebrovascular risk factors (CVRFs) report more depression symptoms (Mast, Yochim, 
et al., 2004; Yochim, Mast, & Lichtenberg, 2003).  Alexopoulos theorized that the behavioral 
and cognitive symptoms characteristic of vascular depression directly result from frontostriatal 
neuropathology of vascular origin. Behavior among individuals with late-onset depression is 
fundamentally vegetative, characterized by a marked loss of interest in activities (Alexopoulos et 
al., 1996; Lockwood, Alexopoulos, & vanGorp, 2002) and deep rumination (von Hippel, Vasey, 
Gonda, & Stern, 2008).   
 
Cognitive Neurophysiology of Vascular Depression. 
Decrement of inhibitory cognitive processes and corresponding neuropathology relate to 
vascular depression and underlie the fundamental connections between depression and other 
geriatric disorders emphasized in the present dissertation. Several avenues of research have 
recently examined the role of inhibition in cognitive functioning broadly speaking (Corbett, 
Constantine, Hendren, Rocke, & Ozonoff, 2009; Zanto & Gazzaley, 2009). Vascular depression 
is, in essence, the loss of cognitive inhibition relative to affective regulation. This specific form 
of cognitive decline signals the existence of diffuse neurological damage and precipitates 
additional neuropathology. 
Numerous morphological differences, primarily relating to the frontal lobe and associated 
structures, have been identified as characteristic of depression.  Often these differences are 
localized to the prefrontal lobe, but other findings suggest widespread morphological differences.  
5 
 
 
 
Postmortem studies indicate that individuals with depression have fewer glia in the dorsolateral 
prefrontal cortex (Rajkowska, Halaris, & Selemon, 2001; Rajkowska et al., 1999), amygdala 
(Bowley, Drevets, Ongur, & Price, 2002), the subgenual anterior cingulate and orbitofrontal 
cortex (Cotter, Mackay, Landau, Kerwin, & Everall, 2001; Ongur, Drevets, & Price, 1998).  
Abnormalities have also been reported in the entorhinal cortex as a result of depression 
(Bernstein, Baumann, Danos, Falkai, & Diekmann, 1998).  Depression in late life has also been 
related to volumetric differences in the prefrontal cortex (Coffey et al., 1993; Goodwin et al., 
1997), orbitofrontal cortical matter (Bremner et al., 2002), subgenual region of the anterior 
cingulate gyrus (Botteron, Raichle, Drevets, Heath, & Todd, 2002), hippocampus (Bremner et 
al., 2000), putamen (Husain et al., 1991) and caudate nucleus (Krishnan et al., 1992), in addition 
to others (discussed in Phillips, Drevets, Rauch, & Lane, 2003).  Phillips et al. (2003) incorporate 
these findings with literature describing altered blood perfusion during depression to articulate a 
neurocircuitry-based model of depression involving relative impairment of executive functioning 
among otherwise healthy adults. Taken together, these findings suggest that late-life depression 
may be characterized by wide-spread neurological changes, likely related to wide-spread though 
subtle behavioral and cognitive changes. 
In a similar vein, Drevets and colleagues (Drevets, Price, & Furey, 2008; Drevets et al., 
1992) proposed a model describing how mood is modulated and expressed through a circuit 
extending from the left ventrolateral prefrontal cortex into the medial prefrontal cortical surface 
implicating the left amygdala.  Greater activity along this pathway was found among individuals 
with depression, but not among depression-free individuals with a family history of mood 
disorders.  This suggests that the activation observed in depressed participants may be a state-
dependent process (Drevets et al., 1992).  Drevets and colleagues (2008) elaborated on this 
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model by discussing the functional roles of other circuits in the management of affect.  In 
addition to the circuit described in the 1992 paper, they described a visceromotor system that has 
connections with limbic structures, the hypothalamus and periaqueductal gray, which is 
responsive to affectively challenging stimuli.  They further described a third pathway: an “orbital 
prefrontal network” that connects central and lateral orbital areas and includes sensory 
association areas, the inferior temporal cortex, the insula and the frontal operculum.  They posit 
that this pathway is recruited for sensory integration and reward, aversion, and identifying 
relative value. 
 Von Hippel et al. (2008) argue that disconnection of a pathway conceptually similar to 
the one described by Drevets and colleagues (Drevets et al., 2008; Drevets et al., 1992) results in 
vascular depression.  As these pathways traverse the subcortical prefrontal region, they may be 
vulnerable to cerebrovascular distress in this region.  Consequently, von Hipple (2008) suggests 
that executive functions in general and the ability to attend to and inhibit depressogenic 
cognitions in particular become impaired.  Such age-related inhibitory deficits have been 
reported in other areas of cognitive neuroscience research (Zanto & Gazzaley, 2009).  They 
suggest impaired ability to inhibit depressogenic cognitions potentiates uncontrolled ruminative 
thinking, resulting in spiraling depression symptoms.  Consistent with this hypotheses, von 
Hipple (2008) reported that ruminative thought mediates the relationship between executive 
functioning deficits and late-onset depression but not in depression among younger individuals.  
This pattern of relationships suggests that affective management deficits, resulting in depression, 
are a harbinger of a broader pattern of age-related cognitive and neurological decline. 
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Frailty 
 Frailty is conceptualized as the combined effects of life stress resulting in multi-systemic 
dysregulation of homeostatic systems.  Although there are multiple models of frailty, Fried’s 
(2001) conceptualization continues to be a leading model and the one utilized in the present 
dissertation.  This model describes frail individuals as having at least three of the following 
conditions: unintentional weight loss, exhaustion, weakness, slow walking speed, and low 
physical activity.  Fried (2001) reported that frailty is more common among individuals who are 
Black, have lower education and income, relatively poor health, and greater medical comorbidity 
and disability.  In keeping with past research (Varadhan et al., 2009), the proposed dissertation 
will conceptualize frailty as the presence of at least three of five indicators of frailty including 
wasting (substantial weight loss), weakness, slowness, fatigue or exhaustion, and recent falls.  
Some studies suggest that frailty is more common among women (Fried et al., 2001), especially 
those with low education (Deeg, Portrait, & Lindeboom, 2002). Others suggest that men are at 
greater risk (Klein, Klein, Knudtson, & Lee, 2005), especially those who live alone (Deeg et al., 
2002).  Frail individuals experience decreased mobility, and heightened rates of activity of daily 
living (ADL) impairment, hospitalization and death (Fried et al., 2001; Lupon et al., 2008).  The 
base rate of frailty is relative to age, with frequencies ranging from 3%-7% of individuals 
between ages 65 and 75 (Fried, 2003) and over 30% for individuals in their 90s (Walston et al., 
2002). 
Frailty is associated with comparably poor subjective health evaluations and higher age-
adjusted rates of myocardial infarction, angina, congestive heart failure, peripheral vascular 
disease, arthritis, diabetes, hypertension and chronic obstructive pulmonary disease (Fried et al., 
2001).  It is noteworthy that frequencies of these comorbidities increase incrementally between 
robust (0 frailty symptoms), intermediate-frail (1 or 2 symptoms), and frail elders (3 or more 
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symptoms).  One example of autonomic dysregulation associated with frailty is greater heart rate 
variability among frail elders (Varadhan et al., 2009). Moreover, the heart rate variability index 
used by these authors predicted mortality in the sample.  Similarly, an index relevant to diabetes, 
insulin resistance as measured by homeostasis model assessment (IR-HOMA) scale was found to 
indicate more disordered metabolic functioning among frail elders (Barzilay et al., 2007). 
 Consistent with greater medical comorbidities associated with this syndrome, frailty also 
relates to higher rates of health care utilization.  After adjusting for demographic variables, 
diabetes, stroke, hypertension, and hyperlipidemia, elders with 1-2 symptoms had odds ratios for 
overnight and emergency room hospital visits of 1.97 and 1.34, respectively.  By contrast, frail 
elders (at least 3 symptoms) had odds ratios for overnight stays and emergency department visits 
of 4.45 and 3.10, respectively, by comparison to robust elders (Kiely, Cupples, & Lipsitz, 2009).  
Similarly, mortality risk escalates with increasing frailty.  Individuals with just one or two 
symptoms of frailty have greater mortality risk than robust elders, and frail elders with three or 
more symptoms have even greater risk of death (Fried et al., 2001; Klein et al., 2005).  Deeg et 
al.(2002) reported that frail women at age 66 have a 7.6 year life expectancy, which was 
considerably shorter than life expectancies for non-frail elders with other health profiles 
including those with cognitive disorders (23.4 years), cardiac disease (16.2 years), or cancer 
(20.2 years). 
 
Depression and Frailty  
 Considerable research on frailty has included mental-health variables such as depression 
measures.  However, much of this research does not explore depression as a direct cause of 
frailty and instead incorporates depression as a control variable or a suppressor variable. Andrew 
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and Rockwood (2007) reported that psychiatric disease broadly defined was relatively rare 
among the least frail elders, and was four times more common among elders who scored in the 
top decile of a frailty measure.  However, interpretation of these results is limited by the use of 
cross-sectional, self-report mental health data, and the authors recognize the impossibility of 
developing a causal model of depression and frailty without longitudinal data.  Nonetheless, 
considerable connections between depression and frailty indicators are implied by the literature. 
 For instance, findings suggest that fall risk, identified in the proposed dissertation as an 
indicator of frailty, is associated with depression (Allan, Ballard, Rowan, & Kenny, 2009; 
Anstey, Burns, von Sanden, & Luszcz, 2008; Byers et al., 2008; P. Thomas et al., 2009).  
Thomas et al.(2009) argue that age-related increases in fall risk are compounded by pathological 
brain changes, such as those observed in vascular depression.  This argument was supported by 
reportedly greater fall risk among elders with both depression and executive dysfunction.  Byers 
(2008) reported that elders who experienced adverse falls had 90% greater probability of 
experiencing significant depression.  Though the relative contribution of depression and 
antidepressant medications to fall risk has been debated, (Kerse et al., 2008; Whooley et al., 
1999), a thorough review of antidepressant use in late life suggests that the risk of fall associated 
with antidepressant use is similar to that in untreated depression (Darowski, Chambers, & 
Chambers, 2009).  
 In addition to the relationship between depression and falls, depression appears to predict 
other aspects of frailty.  For instance, Thomas et al.(2009) presented results suggesting that 
depression and executive dysfunction, such as that observed in vascular depression, precipitate 
malnutrition, which can lead to wasting.  In fact, depression has been identified as the leading 
cause of weight loss among nursing home residents (Morley & Kraenzle, 1994). Among older 
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men, depression was found to relate to steep decline in strength (Rantanen et al., 2000). Such 
muscle loss could contribute to slowness and weakness, both of which are characteristic of 
frailty.  Depression was also found to be a strong predictor of ADL functioning and mobility 
problems over 6-years (Penninx, Leveille, Ferrucci, van Eijk, & Guralnik, 1999).  Additional 
parallels between frailty and depression will be addressed below. 
 
Cognitive Decline 
 Normative cognitive change in late life can be described as gradual changes affecting 
different facets of cognitive functioning such as processing speed (Salthouse, 1992a, 1992b, 
1996), episodic memory (Naveh-Benjamin, Guez, & Shulman, 2004), or sensory function (Baltes 
& Lindenberger, 1997) that cause decline but do not severely handicap an individual’s capacity 
for self-care. By contrast, catastrophic cognitive decline or terminal decline is identified as an 
accelerated loss of functioning preceding death.  As an example, it was recently reported that 
elders with sharp declines on the Mini Mental State Exam experienced more ADL disability and 
higher mortality rates (Yaffe et al., 2010).  While estimates of the temporal relationship between 
terminal decline and death vary, recent research identified evidence of terminal decline at a mean 
of 42 months before death (R. S. Wilson, Beck, Bienias, & Bennett, 2007).  Another study 
reported that for individuals between 60 and 74 years of age, the relationship between cognitive 
functioning and mortality was negligible after controlling for health behaviors; however, 
impaired cognitive functioning significantly predicted incidence of death for individuals 75 years 
and older (Gillum & Obisesan, 2010).  Between elders with similar levels of cognitive 
functioning, idiographic variability on measures of processing speed has been demonstrated to 
predict mortality (MacDonald, Hultsch, & Dixon, 2008).  Though outside the scope of the 
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present dissertation, this finding suggests an interesting parallel between cognitive decline and 
frailty.  Dysregulation in frailty is often characterized as greater variability.  
While cognition can be assessed in very narrowly-defined terms, the present research 
conceptualizes cognitive functioning as a reflection of generalized neurological integrity that can 
be grossly assessed using a brief screening measure.  For instance, performance on brief screens 
such as the Mini Mental State Exam is adversely affected by generalized cerebral atrophy, 
infarcts, periventricular white matter hyperintensities (WMHs; Prins et al., 2005) and ventricular 
volume (Jack et al., 2004). While brief screening instruments of gross cognitive functioning 
should not be used to diagnose geriatric cognitive disorders, performance on such instruments is 
predictive of dementia (Schultz-Larsen, Lomholt, & Kreiner, 2007) and mortality (Schultz-
Larsen, Rahmanfard, Kreiner, Avlund, & Holst, 2008). Cognitive decrement among elders, 
regardless of etiology, produces deficits in ecological functioning. 
 
Cognitive Decline in Relation to Depression and Frailty. 
 Several other studies are of particular importance in understanding late-life cognitive 
decline within the context of mood and longevity.  Of particular relevance to the present 
dissertation, emerging research (Bielak, Gerstorf, Kiely, Luszcz, & Anstey, 2010) supports older 
findings (Butters et al., 2000) suggesting that depression symptoms precede terminal decline.  
With respect to longevity, research by both Mehta et al. (2003) and Arfken et al. (1999) suggests 
that the relationship between terminal cognitive decline and death is moderated by depression 
symptoms; elders with the most impaired cognitive functioning and the most depression 
symptoms were found to have the highest mortality risk.  By contrast, other researchers have 
reported that among the oldest old, depression does not signal prospective loss of cognitive 
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functioning, but rather that cognitive decline at baseline indicates risk of increasing depression 
symptoms (Vinkers, Gussekloo, Stek, Westendorp, & van der Mast, 2004). Variability in these 
findings likely reflects a reciprocal, synergistic relationship between these factors. 
While it is evident that a relationship exists between cognitive functioning and frailty, the 
direction of this relationship is not clear. For example, accelerated weight loss, such as that seen 
in frailty, precedes the onset of Alzheimer’s disease (Johnson, Wilkins, & Morris, 2006). By 
contrast, a study of dementia-free elders, cognitive functioning at baseline and subsequent 
change in cognitive functioning predicted increasing frailty (Buchman, Boyle, Wilson, Yuxiao, 
& Bennett, 2007).  Similarly, this variability likely signals close interrelationships between 
cognitive decline and frailty. 
 
Vascular Depression as a Marker of Global Cerebral Disease Process 
 Vascular depression is conceptualized as a prodrome for frailty and cognitive decline.  As 
described above, vascular depression has a neurological basis.  As such, mood declines are 
hypothesized to result from the same neuropathology that causes frailty and terminal decline.  
Because mood is mediated by specific neurological pathways described above, it may be a more 
sensitive indicator of late-life neurological change than either cognitive or motor functioning.  In 
this way, vascular depression may be a marker of global cerebral disease process and a harbinger 
of subsequent frailty, cognitive decline, and mortality. 
 Katz (2004) discussed considerable theoretical and phenomenological similarities and 
connections between depression and varying models of frailty.  He notes that white matter 
disease, a common characteristic of abnormal cerebral aging, characterizes both late-onset mood 
disorders such as vascular depression and psychomotor deficits which can be symptomatic of 
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frailty.  A corollary of this argument is that the cerebrovascular disease that causes prefrontal 
white matter hyperintensities and vascular depression could also lead to posterior white matter 
hyperintensities resulting in falls and other motor deficits such as slowness and weakness.  
 Atkinson et al. (2010) have made arguments that cognitive deficits and motor deficits 
appear to be related because they share a common cause: global central nervous system 
degradation.  Atkinson and colleagues (2010) discuss how cognitive decline may precede deficits 
in motor functioning.  Citing the finding that elders with progressive dementia demonstrate 
cognitive impairment often long before psychomotor functioning deficits (Njegovan, Man-Son-
Hing, Mitchell, & Molnar, 2001), they hypothesized that cognitive functioning may simply be 
more sensitive to global neuropathology.  This theory was further based on evidence that elders 
increasingly recruit frontal areas for basic cognitive functions as posterior structure atrophy 
accumulates (Heuninckx, Wenderoth, Debaere, Peeters, & Swinnen, 2005). In this way, 
psychomotor deficits might be disguised while executive functioning declines. Maintenance of 
mood involves an elaborate network of fronto-striatal projections (Drevets et al., 2008), and 
appears to be very sensitive to neurological insult (Sneed et al., 2008).  Consistent with Atkinson 
and colleagues’ (2010) first argument, it may be that a decline in mood is an early indicator of 
global CNS neuropathology that is not yet severe enough to cause cognitive and psychomotor 
deficits such as those seen among frail individuals.  In this way, vascular depression may be an 
early indicator of frailty and suggest a higher mortality risk. 
Vascular dementia provides another example of how late-life depression can be a marker 
of global cerebral deterioration.  Vascular dementia is identified clinically as diffuse cognitive 
impairment in the presence of multiple cerebrovascular risk factors and widespread WMHs on a 
T2 weighted MRI.  These hyperintensities indicate areas of white matter disease, typically 
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caused by microstrokes, ischemic blockages of microvasculature, or other cerebrovascular 
disease.  Among  individuals with vascular dementia, subcortical WMHs were associated with 
decreased cerebral bloodflow and cortical atrophy (Schuff et al., 2009). Vascular depression and 
vascular dementia result from similar vascular factors.  Vascular disease broadly speaking, and 
microbleeds in particular, have been identified as a leading predictor of mortality among a 
sample of patients with memory disorders, including vascular depression patients, regardless of 
memory disorder diagnosis (Henneman et al., 2009).  Given the relationship between 
cerebrovascular burden and mood described above, these findings are consistent with the 
hypothesis that late-life depression may be a sensitive and clinically relevant indicator of an 
underlying disease process. 
Another example of progressive decrement of mood, cognitive, and psychomotor 
functioning is Alzheimer’s disease (AD).  Alzheimer’s accounts for the majority of late-life 
dementia diagnoses and poses a significant mortality risk to elders.  Evidence of very modest 
cognitive decline distinguishes those at risk for diagnosis of Alzheimer’s disease several years 
before significant memory impairments are noticed.  This suggests gradual development of 
subclinical neuropathology over the course of many years. However, individuals typically do not 
manifest clinically-significant cognitive deficits until brain reserve, compromised by 
neuropathology, crosses an idiographic threshold (Satz, 1993). Consistent with the hypothesis 
that mood is a more sensitive indicator of global neurological decline, a growing body of 
research suggests that depression symptoms also precede Alzheimer’s disease, often occurring 
within a year of clinically significant memory loss (Green et al., 2003). Moreover, neurofibrillary 
tangles and beta-amyloid plaques are more prevalent in Alzheimer’s patients with significant 
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depression symptoms than those without (Rapp et al., 2008), further suggesting parallel 
underlying disease processes for Alzheimer’s disease and at least some subtypes of depression.   
Specific Hypotheses  
This dissertation includes four separate empirical studies, each testing a hypothesis drawn 
from the theoretical model outlined above.  The first paper tests the hypothesis that education, 
characterized as brain reserve, protects elders from development of depression symptoms 
secondary to high CVB-mediated neurological change.  The second paper relates CVB, 
depression, and cognitive functioning to the three domains of Rowe and Kahn’s (1997) 
successful aging theory, and use these variables to predict incidence of death.  The third paper 
tests the hypotheses that vascular depression predicts incidence, and prevalence, of frailty.  The 
fourth paper tests the theory that vascular depression predicts mortality indirectly through frailty. 
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CHAPTER 2 
Does Brain Reserve Protect Older Women from Vascular Depression? 
Abstract 
 Cerebrovascular burden (CVB) in contributes to neurological changes associated with new onset 
“vascular depression” in late life.  Brain reserve theory, typically discussed in relation to 
dementia, was examined with regard to late life depression and cerebrovascular burden in older-
old women. It was predicted that in a longitudinal sample (Health and Retirement Survey) of 
stroke-free women over the age of 80, higher levels of depression would be predicted by high 
CVB (more than two of the following: heart disease, diabetes, hypertension and lifetime history 
of smoking) and less educational attainment, after controlling for age and gross cognitive 
functioning.  Depressive symptoms were assessed using the 8-item Center for Epidemiological 
Studies (CSED) measure, and cognitive functioning was measured using the 35-point Telephone 
Interview for Cognitive Status (TICS).  Because of high attrition related to death and incapacity 
in this sample, multiple imputation based on self-rated health, activities of daily living and 
instrumental activities of daily living was used to specify missing data.  A latent growth curve 
was used to identify differences in depression at baseline and over time based on CVB, cognitive 
functioning, education and age.  Results indicate that at any level of CVB, older women with 
more education experienced fewer depression symptoms.  Results support brain reserve theory 
and the vascular depression hypothesis.  These results suggest that having greater education may 
postpone development of clinically-significant depressive symptoms resulting from high CVB, 
thereby preserving mood in late life. 
  
17 
 
 
 
Introduction 
Depression is both common and medically relevant in late life.  One recent study of  335 
community dwelling older adults reported a normative increase in depression symptoms after the 
age of 77 (Teachman, 2006).  The negative impact of depression in late life is highlighted by 
previous findings that depression was identified as the leading cause of disability worldwide, and 
that depressive symptoms in late-life predicted cognitive decline, higher levels of disability, and 
mortality (Blazer, 2003).  The importance of mood as a clinical indicator of depressive 
symptoms is underscored by its utility in predicting these adverse health outcomes.  Specifically, 
self-reported depressive symptoms were found to predict increased stroke risk (Bos et al., 2008; 
Larson et al., 2001; Salaycik et al., 2007), first heart attack (Glassman & Shapiro, 1998), and 
cancer (Penninx, Guralnik, et al., 1998), impaired immune functioning in general (Kiecolt-Glaser 
& Glaser, 2002; Salzet et al., 2000) and the increase of proinflamatory cytokines, IL-6 in 
particular (Dentino et al., 1999; Lutgendorf et al., 1999; Maes et al., 1995; Maes et al., 1999; 
Maes et al., 1998), and increased mortality (Arfken et al., 1999; Covinsky et al., 1999; Mehta et 
al., 2003).  
Late Life Depression subtype: Vascular Depression 
One attempt to better understand late life depression has been the Vascular Depression 
hypothesis (Alexopoulos et al., 1997a). Vascular depression theory suggests that cerebrovascular 
burden (CVB)  may predispose, precipitate and perpetuate symptoms of depression in late life 
(Alexopoulos et al., 1997b). Cerebrovascular burden predicts diffuse deterioration in the central 
nervous system (C. J. Wilson, Finch, & Cohen, 2002), and prefrontal white-matter 
hyperintensities in particular (Coffey, Figiel, Djang, & Weiner, 1990; Raz, Rodrigue, & Acker, 
2003).  Late-life depression was associated with damage to frontostriatal white matter tracks, 
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termed white matter hyperintensites (WMHs; Fujikawa, Yamawaki, & Touhouda, 1993; 
Krishnan, Hays, & Blazer, 1997). WMHs in late life were associated with cerebrovascular 
burden (Cohen et al., 2009) and executive functioning deficits (Raz et al., 2003). When found in 
greater magnitude, WMHs predated late-onset depression (Nebes et al., 2002), but not depression 
among middle-aged individuals (Salloway et al., 1996). Our research group found that clinically-
defined vascular depression was best measured as a threshold effect whereby elders with two or 
more cerebrovascular risk factors (CVB group) have more depressive symptoms than those with 
0 or 1 risk factor (Mast, Azar, & Murrell, 2005; Mast et al., 2008; Mast, Yochim, et al., 2004; A. 
J. Thomas et al., 2001; Yochim et al., 2003). Importantly, older adults with both depression 
symptoms and cognitive deficits have a three times higher mortality risk than their counterparts 
(Blazer, 2003; Mehta et al., 2003), making cognitive functioning an important control variable in 
studies of this kind.  
Most studies of vascular depression have mixed middle aged, younger old (65-79 years) 
and older old (80+) together (Alexopoulos et al., 1997a; Luijendijk, Stricker, Hofman, Witteman, 
& Tiemeier, 2008; Mast, Yochim, et al., 2004; Mehta et al., 2003).  This methodology may mask 
some of the unique vascular depression patterns in the oldest old.  Women over 80, in particular, 
represent the fastest growing target group for medical and behavioral interventions to enhance 
longevity and reduce morbidity. Between 2004 and 2006, the percentage of women in the U.S. 
over age 85 grew by 40% (U.S. Bureau of the Census, 2004, 2006). Moreover, by comparison to 
men, older women also have higher rates of depression, longer life expectancies, and experience 
more years of disability (von Strauss, Aguero-Torres, Kareholt, Winblad, & Fratiglioni, 2003). 
Thus, research examining the relationship between cerebrovascular burden and depression 
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among older women may inform interventions designed to effectively reduce dependence, the 
need for health and social services, and medical care costs in later life (see Blazer, 2003).  
Vascular depression, like dementia, is associated with progressive neuropathology that 
results in behavior changes.  Among neuropathological markers associated with late life 
depression, prefrontal WMHs, characteristic of high cerebrovascular burden (CVB; Cohen et al., 
2009) are the most robust indicator.  For instance, both prefrontal white matter hyperintensites 
(WMHs; Coffey et al., 1990; Nebes et al., 2002) and hippocampal volume loss (Ballmier et al., 
2008) are associated with depression in late-life, but not in mid-life (Salloway et al., 1996).  
Late-life depression has also been related to differences in volumetric measurements of the 
caudate nucleus (Krishnan et al., 1992) and the dorsolateral prefrontal cortex (A. J. Thomas et 
al., 2003), in addition to differences described elsewhere (Wright & Persad, 2007).     
Vascular Depression and Brain Reserve 
Brain reserve theory has been proposed as an explanation for why considerable inter-
individual variation exits with regard to behavioral response to brain changes. Experiences in 
early life, such as education, for example, are associated with greater synaptic density, described 
as brain reserve capacity (Stern, 2002).  Years of education appears to be the most commonly-
used indicator of brain reserve (Valenzuela & Sachdev, 2006b). As demonstrated by the Nun 
study (Mortimer, Snowdon, & Markesbery, 2003) individual response to neurological change is 
moderated by individual factors such as educational attainment in early life.  Sixteen of the 34 
nondemented, but highly educated sisters had neuropathology consistent with Alzheimer’s 
disease.  Some synaptic loss is characteristic of late-life brain changes; however, passive brain 
reserve theory posits that significant behavioral pathology develops only when synaptic 
availability declines past an idiographic threshold (Stern, 2002). Using Alzheimer’s disease as an 
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example, Stern (2002) describes how educational experiences impart greater synaptic complexity 
and thereby reduce expression of clinically-significant cognitive deficits. Similarly, two 
complementary meta-analyses of 22 brain-reserve related cohort studies representing over 
29,000 participants found that education and preference for stimulating leisure activities 
protected against cognitive decline (Valenzuela & Sachdev, 2006a), and that education, 
intellectual functioning, occupational functioning, and preference for stimulating leisure 
activities, all were associated with reduced incidence of dementia by around 50% (Valenzuela & 
Sachdev, 2006b). In a sample of 872 older participants, more education reduced the risk of 
dementia at any level of neuropathology based on cortical atrophy, hippocampal atrophy, or 
Braak stage (EClipSE Collaborative Members, 2010).  A complex array of mechanisms ranging 
from variability in brain-derived neurotrophic factor to compensatory network recruitment have 
been proposed to explain how brain reserve translates into preserved cognitive functioning 
(Valenzuela, Breakspear, & Sachdev, 2007).  
Given the neurological basis of vascular depression, it may be valuable to investigate the 
brain reserve hypothesis in a geriatric sample.  Brain reserve theory predicts that well-educated 
individuals may have fewer depression symptoms in late life, even in the face of cerebrovascular 
burden. Consistent with this hypothesis, a large, multinational cross-sectional study reported a 
relationship between educational attainment and depression in later life, independent of 
socioeconomic conditions (Ladin, 2008) such that participants with greater education had lower 
rates of depression. This study did not examine, however, the influence of either CVB or 
education on the development of depression symptoms over time and did not employ a measure 
of cognitive functioning. Similarly, Schoevers and colleagues (2003) found that in a sample aged 
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65-84 years, having 8 or fewer years of education related to greater chronic depression for men, 
but not for women.  Less research has evaluated these relationships among the older-old. 
Purpose of the Study 
The aims of this longitudinal study are to examine how CVB and education predict 
number of depressive symptoms at baseline, and the development of depressive symptoms over 
time in a sample of women in the community over the age of 80. Specifically, we will investigate 
whether higher levels of education postpone the rise of depressive symptoms in the face of 
Cerebral Vascular Burden. Broadly speaking, brain reserve theory suggests that the normative 
late-life rise of depressive symptoms, a behavioral marker of cerebral decline, will be postponed 
among elders with more education. Does this pattern hold even when CVB is present? This study 
also aims to measure rates of vascular depression, more akin to clinical research, by using 
established cutoff scores and examining rates of depression by CVB and education. 
Hypothesis 1: Older adults with CVBs will have greater symptoms of depression at 
baseline and across the six year follow up period.  Additionally, the relationship between CVBs 
and depression symptoms will be moderated by education whereby education will protect against 
development of depressive symptoms. 
Hypothesis 2:  Older adults with lower levels of education will have greater symptoms of 
depression at baseline and across the six year follow up period.  
Hypothesis 3: Regardless of CVB level, brain reserve theory predicts that older adults 
with more education will have delayed onset of late-life depression symptoms.  As such, fewer 
depression symptoms at baseline may predict greater development of symptoms, indicated by 
greater slope in depression symptom development, over the course of the study. 
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Method 
Sample 
 The Health and Retirement Survey (HRS) is a prospective cohort study conducted by the 
University of Michigan with support from the National Institute on Aging. The first wave of the 
HRS occurred in 1992 with a 51 to 61 year-old cohort and was merged with the older (70 years 
and older) Asset and Health Dynamics of the Oldest Old Study (AHEAD) cohort in 1998. Two 
additional cohorts were added in 1998 to fill in the gaps between these two groups. Briefly, the 
HRS is a multistage probability cohort sample of U.S. households. Further details on the HRS 
design and methods have been previously published (Heeringa & Conner, 1995).  
 Four waves of data (1998 to 2004) from the HRS and the RAND Center for the Study of 
Aging were analyzed in this study ("RAND HRS Data, Version F," 2006). We analyzed data 
from 1,355 community-dwelling older women who were 80 years or older in 1998. Respondents 
were excluded if they were unable to complete testing without assistance (proxy). Because stroke 
is associated with subsequent depression symptoms (Bour et al., 2009), respondents were 
excluded from this study if they reported a history of stroke. Over the course of this study (years 
1998 – 2004), the combined year response rate was 37.9% and wave-to-wave re-interview 
response rates ranged from 73.0% (2000) to 74.4% (2002). The baseline characteristics of the 
sample are displayed in Table 1. Of the 1355 individuals with complete baseline data, 514 
completed the CESD scale across all waves of this study. Attrition rates in the HRS are 
comparable to that of other panel surveys (Groves & Couper, 1998) and sample attrition has not 
significantly influenced the representativeness of the remaining sample based on demographic, 
economic, and health measures (Cao & Hill, 2005). However, women over age 80 have higher 
mortality rates than the general population. Respondents missing by the end of the study (year 
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2004) were older (t=-11.654, p<.001), with fewer years of education (t=4.593, p<.001), more 
likely to have high CVB (X2=15.987, p<.001) and depression scores (U=187997.5, p<.001) and 
lower TICS scores (X2=117.6, p<.001) than their counterparts. Of the 808 respondents lost 
between baseline and 2004, 605 were identified as deceased and the vast majority of the 
remaining 202 respondents responded by proxy, suggesting incapacity.  The sample is described 
in Table 2.1. 
Measures 
Depression 
The dependent variable, depression symptoms, was measured by a Center for 
Epidemiologic Studies—Depression scale (CES-D)(Radloff, 1977). Respondents were asked if 
they were depressed, if everything was an effort, if their sleep was restless, were happy, lonely, 
enjoyed life, felt sad and could not get going (yes/no within the week prior to the interview). 
Higher CESD scores reflected more depressive symptoms and a CESD score ≥3 was used to 
indicate clinical depression (Steffick, 2000). The 8-item CES-D has similar symptom dimensions 
as the 20-item CES-D and past research suggests high internal consistency (α = .77) and validity 
of the CES-D as implemented in the HRS (Steffick, 2000; Wallace et al., 2000).  
Cerebrovascular Burden  
Cerebrovascular burden (CVB was based on doctor diagnosed self-reports of 
hypertension, heart disease, diabetes and smoking. At baseline, respondents were asked if a 
doctor had ever told them that they had these conditions (i.e., measure of prevalent conditions). 
In later survey waves, respondents were asked if they had been told by a doctor (since the prior 
interview) that they had developed any of these conditions. Reasonable concordance values 
between self-reports of disease and medical chart reviews have been reported (Bush, Miller, 
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Golden, & Hale, 1989; Psaty et al., 1995). Consistent with previous work (Mast, MacNeil, & 
Lichtenberg, 2004; Mast, Yochim, et al., 2004; Yochim et al., 2003), respondents were 
categorized into low and high cerebrovascular burden (CVB) groups based on the report of either 
low (0-1) or high (2-4) CVB risk factors.  
Demographic Variables 
 Age was calculated based on reported birth date. Education was assessed as self-reported 
years of formal schooling. Participants were identified as having low (12 years or less) or high 
(more than 12 years) of education. 
Cognitive Functioning 
 Cognitive functioning was measured by the modified Telephone Interview for Cognitive 
Status (TICS) included in the AHEAD/HRS data (Ofstedal, Fisher, & Herzog, 2005).  This test is 
based on the older TICS measure published by Brandt, Spencer and Folstein (1988) and is a brief 
standardized test developed for remote screening of cognitive disorders.  Because cognitive 
functioning has been identified as a confounding variable in the relationship between CVB and 
depressive symptoms (Mast, Yochim, et al., 2004), it was controlled for using this brief cognitive 
screen.  TICS measures orientation, concentration, short-term memory, mathematical skills, 
praxis and language with the maximum score of 35 reflecting higher cognitive functioning. The 
TICS has high test-retest reliability and is generally sensitive to cognitive impairment (Brandt et 
al., 1988; Desmond, Tatemichi, & Hanzawa, 1994; Järvenpää et al., 2002; Welsh, Breitner, & 
Magruder-Habib, 1993). The sample was divided into low (scores lower than 17) and high (score 
of 17 or greater) scoring groups using a median split of TICS scores.  
Auxiliary Variables  
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 Self-rated health was assessed using the question, “Would you say your health is 
excellent, very good, good, fair, or poor?” The self-rated health Self-rated health has been 
identified as a leading indicator of mortality across studies, including the HRS/AHEAD sample 
(Siegel, Bradley, & Kasl, 2003).  The Activities of Daily Living (ADLs) scale assessed self-
reported difficulty walking across a room, getting in and out of bed, dressing, bathing and eating 
and produces a score ranging from 0-5.   Instrumental Activities of Daily Living (IADLs) was 
measured using a 3-question instrument including items assessing difficulty with using the 
telephone, taking medication and handling money and produces a score ranging from 0-3.  
Cumulatively, these variables accurately identified 79.4% of the attrited participants, and all 
three variables significantly predicted attrition (p≤.001). 
  
Statistical Methodology 
Longitudinal research with the older-old is complicated by attrition reflecting the 
extremely high mortality risk and threat of incapacity.  It has been argued that in cognitive aging 
research, disregarding participants with missing data resulting from death or drop-out results 
produces a systematic underestimation of disorder severity and only the most robust elders are 
represented (Rabbitt, Lunn, & Wong, 2008).  McArdle and Hamagami’s (1991) seminal work 
used maximum likelihood estimation to analyze longitudinal datasets with significant missing 
data. More recently Graham (2003) has built on this methodology by including auxiliary 
variables in the imputation of missing data. Like cognitive decline, depression predicts mortality 
and incapacity in late-life.  For this reason, it is appropriate to utilize an analytic strategy that 
permits inclusion of baseline respondents who attrite over the course of the study.   
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 Data were analyzed using a latent growth curve (LGC) modeling approach specifically 
designed to account for missing data (e.g., Enders, 2010). This aim was achieved within the full 
maximum likelihood (FIML; e.g., Arbuckle, 1996) estimation framework with informative 
covariates. To this end, use of suitably chosen auxiliary variables was made (e.g., Graham, 
2003), which represents a modern principled method for dealing with missing data that is 
implemented in the popular latent variable modeling software Mplus (Muthen & Muthen, 2010). 
Specifically, variables that were judged on substantive grounds to be related to the missing 
values were utilized as auxiliaries in all models fitted to address the research questions pursued 
in this paper. These variables were self-rated health, activities of daily living, and instrumental 
activities of daily living.  In this way, data from all 1355 subjects in the available sample was 
used, regardless of number of repeated measures of depression that each one of them provided. 
In addition, through the inclusion of the above auxiliary variables, important information about 
the missing values – as contained in those variables – was incorporated into the model fitting and 
parameter estimation process (e.g., Little & Rubin, 2002). For all LGC models reported in this 
article, we used the robust maximum likelihood method of estimation (e.g, Muthen & Muthen, 
2010) to handle some marked deviations from normality in their dependent variables.  
In order to develop the (unconditional) LGC model, we examined the patterns of 
temporal change in depression using the Intercept-and-Slope model (IS model; e.g., Raudenbush 
& Bryk, 2002; Raykov & Marcoulides, 2008). This unconditional model does not include 
predictors and correlates of change patterns, while describing the individual development over 
time in depression as following a linear regression with assessment occasion playing the role of 
predictor variable. Specifically, this two-level model is based on the subject-level (level-1) 
equation 
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(1)  yit = ai + bi (t-1) + eit , 
 
where yit is the depression score of the ith elderly person at tth assessment occasion (t = 1, 2, 3, 
4), ai and bi are his/her starting position (initial depression) and rate (slope, gradient) of change 
in depression over time, and eit is the associated error term (use of t-1 as a formal predictor 
allows interpretation of the intercept ai as a starting position in depression, i.e., initial depression; 
e.g., Raudenbush & Bryk, 2002; i = 1, …, n, with n = 1355 denoting sample size).  
 The level-II model specified fixed and random effects for CVB (dichotimized), cognitive 
functioning (dichotomized), education (continuous), age (continuous), and the interaction of 
CVB and education.  Then, a latent-growth curve was used to assess how these variables 
predicted change in depression over time.  Finally, a post-hoc model was developed based on 
results of the previous latent-growth model, omitting the CVB by cognitive functioning 
interaction term. 
 In addition to the use of latent growth curve models, we completed a basic threshold 
analysis using CVB and education to predict frequency of probable depression in surviving 
participants at each wave.  Consistent with the latent growth curve model, CVB was 
dichotomized so that respondents with 2 or more risk factors were identified as high CVB and 
those with 0 or 1 risk factor were identified as having low CVB.  The education variable was 
also dichotomized so that those with 0-12 years of education were in the low education group 
and those with more than 12 years were in the high education group.  Respondents with probable 
depression were identified as having a CES-D cutoff score of 3 or more and 5 or more based on 
recommended liberal and conservative clinical cutoffs for this instrument (Steffick, 2000). 
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Results 
Level-I Model 
The IS model defined in Equation (1) was then fitted to the data from the four repeated 
assessments of depression, and found to be associated with the following fit indexes (e.g., 
Raykov & Marcoulides, 2006): chi-square (
2
) = 4.078, degrees of freedom (df) = 5, associated 
p-value (p) = .538, and root mean square error of approximation (RMSEA) = 0, with a 90%-
confidence interval (0, .034). Goodness of fit indexes indicated a tenable model, and the linear 
change model adequately described the four waves of   depression data. Nonlinear models were 
also explored but the linear equation (as opposed to quadratic) was a better fit to the data.  
Next, we examined the estimates of the means and variances of the random effects (intercept and 
slope, i.e., starting depression and rate of its change) in this model. The estimate of mean starting 
depression (mean intercept) was 2.112, with a standard error (SE) of .052, and associated p-value 
p < .001, indicating significant mean initial depression level as could be expected. The mean 
slope was estimated at .034, SE = .026, p = .191. This result indicated that the average slope (rate 
of change over time in depression) was not significant in the sampled population. 
Level-II Model 
To gain further insight into these findings, we examined the individual differences in 
starting position and rate of change in depression, as reflected in the variances of these two 
random effects (intercept and slope). Specifically, the variance of initial depression was 
estimated at 2.353, SE = .194, p < .001 (two-tailed), indicating that there were significant 
individual differences in starting depression. The variance in the rate of temporal change in 
depression was estimated at .142, SE = .046, p = .002 (two-tailed), i.e., also significant. This 
finding indicated that while the average slope of depression change over time was not 
significant, there were considerable individual differences in the rate of change in depression – 
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some elderly increased while others decreased in their depression. Thereby, the correlation 
between starting position and rate of change in depression was estimated at .262, SE = .102, p = 
.010. This result indicated (unconditionally) that lower starting levels of depression were 
associated with higher rates of changes in depression over time. 
Conditional Latent Growth 
While the unconditional IS model examined the patterns of change in depression over 
time, it did not explain individual differences in these patterns in terms of other variables. To  
address this question, we fitted next the conditional IS model that explained individual 
differences in starting depression and rate of change in it in terms of individual differences of 
CVB (dichotomous; denoted next x1), cognitive functioning (dichotomous; x2), education 
(continuous; x3), age (continuous; x4), and the interaction of CVB with education (x5). 
Specifically, this conditional model was defined by the following equations (e.g., Raudenbush & 
Bryk, 2002; Raykov & Marcoulides, 2008): 
 
(2)  yit = ai + bi (t-1) + eit , 
  ai = 00 + 01 x1i + 02 x2i + 03 x3i + 04 x4i + 05 x5i + i , 
   bi = 10 + 11 x1i + 12 x2i + 13 x3i + 14 x4i + 15 x5i + i 
 
(i = 1, …, n). When fitted to the data, this two-level model was found to be associated with the 
following fit indexes: 
2
 = 6.706, df = 15, p = .965, RMSEA = 0, with a 90%-confidence interval 
(0, .001). These goodness of fit measures indicate a tenable model. Its parameter estimates of 
particular interest for this paper are presented in Table 2.2. 
Post-Hoc Conditional Latent Growth Model 
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As seen from Table 2.2, the CVB and education interaction was found to be non-
significant, controlling for age and cognitive functioning as well as the main effects for CVB and 
education.  In the next fitted model, we dispensed with this interaction, i.e., fitted the LGC model 
defined in Equations (2) without the predictor denoted x5 (interaction term). This more 
parsimonious model was similarly associated with tenable fit indexes: 
2
 = 5.896, df = 13, p = 
.950, RMSEA = 0, with a 90%-confidence interval (0, .001). Its parameter estimates of particular 
relevance for this paper are presented in Table 2.3, and mean scores generated based on these 
results are displayed in Figure 2.1. 
 The top panel results in Table 2.3 suggest that once controlling for age, CVB and 
cognitive functioning, education explains a significant portion of individual differences in initial 
depression. Thereby, for respondents of the same age, CVB and cognitive functioning level, 
those with higher education had lower starting levels of depression. Similarly, CVB is uniquely 
significant after controlling for age, education, and cognitive functioning. That is, older adults 
with higher cerebrovascular burden show higher level of depression at start of study. Both age 
and cognitive functioning, however, are not uniquely significant. For otherwise-similar 
respondents, neither age nor cognitive functioning are associated with higher/lower initial 
depression.  
The lower panel of Table 2.3 indicates that only education has unique predictive power 
with respect to rate of change in depression. Specifically, for elderly of the same age, with CVB 
and cognitive functioning, higher education is associated with higher rates of change in 
depression. We stress however that respondents with higher education tend to be among those 
with lower starting position on depression, as indicated in the top panel of Table 2 and 
mentioned above. We also note that this finding is consistent with the earlier indicated result of 
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significant and negative correlation between starting position and rate of temporal change in 
depression, which was obtained with the unconditional IS model fitted and reported first in this 
section.   
Last but not least, the lower panel of Table 2.3 also indicates that none of the remaining 
three predictors is associated with unique explanatory power with regard to individual 
differences in rate of change in depression. That is, age, CVB, and cognitive functioning do not 
explain differences in rate of change in depression once accounting for the remaining three 
predictors of this quadruple of explanatory variables. 
 
Threshold Analysis 
 Relative frequencies of clinically significant depression between respondents with high 
and low CVBs and education were compared using chi-square tests of independence. 
Respondents were initially identified as having probable depression if they had CESD scores 
equal to or greater than 3. To ensure that this result was not exclusively attributable to high base 
rates of probable depression in a large sample, these analyses were repeated with the probable 
depression group identified as those with CESD scores of 5 or more. 
Using a cut-score of 3 on the CESD, a base rate for likely depression was identified as 
33.5%.  Using a cut-off score of 5 on the CESD produced a 14.8% base rate of probable 
depression.  Illustrated in Table 4, all comparisons in both analyses using the more or less 
stringent cut score, indicated greater frequencies of probable depression among respondents with 
high CVBs and 12 years or less of formal education.  Post-hoc analyses using stepwise logistic 
regression to predict membership in the “likely depression” group based on education,  CVB and 
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an education*CVB interaction term produced results similar to those in Table 2.4.  Inclusion of 
the interaction term did not improve prediction of probable depression (results not shown). 
Discussion 
The primary purpose of this paper was to determine whether education reduces the rate of 
depression in late life, and if so, whether this pattern reflects postponement of the onset of 
depression symptoms in older-old women. The present results indicate that more education 
predicts fewer depressive symptoms among women over the age of 80.  Interestingly, older 
women with more education reported fewer symptoms at baseline, but more rapid development 
of symptoms over the course of the study.  Moreover, the relative benefits of education was 
robust regardless of CVB level.  Depression symptoms at baseline were also significantly 
predicted by CVB.  In this sample, it was also found that probable depression was less likely 
among older women with post-secondary education.  Consistent with past research, high CVB 
predicted greater risk of probable depression (Mast, Neufeld, MacNeill, & Lichtenberg, 2004; 
Mast, Yochim, et al., 2004; Yochim et al., 2003).  
The finding that educational attainment relates to fewer depression symptoms in late life 
is consistent with previous work based on cross-sectional samples (Ladin, 2008) and research 
with limited longitudinal data (Schoevers et al., 2003).  By contrast to existing literature, 
Schoevers et al (2003) reported that the relationship between education and depression was 
found for older men, but not older women.  In the present sample, this relationship was robust 
among women over the age of 80. This difference may relate to Schoevers and colleagues’ 
delineation of “low education” group as those with 8 years of education or less; a group that 
included 42.4% of their sample (Schoevers et al., 2000). By contrast, the multi-level model 
employed in the present study described the effect of education as a continuous variable.  The 
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present research builds on these findings by examining longitudinal development of depressive 
symptoms in an older-old sample.  Additionally, these findings suggest that Stern’s (2002) 
conceptualization of brain reserve capacity, characterized by differential frequencies of symptom 
threshold by education, is applicable to the late-life development of depression symptoms. These 
results also support neurological functioning as a significant component of late-life depression 
(Sneed et al., 2008; von Hippel et al., 2008). 
These findings are also generally consistent with the vascular depression hypothesis 
(Alexopoulos et al., 1997a) and previous findings (Mast, Yochim, et al., 2004; Mehta et al., 
2003) relating CVB and late-life depression. The finding that threshold levels of CVBs predict 
both number of depression symptoms as well as probable depression has important implications 
for clinicians. Although research on the mechanisms of vascular depression will continue to 
evolve, primary care practitioners can use this simple method of calculating cerebrovascular 
burden as a guide to heightened risk of depression in older patients.  The longitudinal data 
suggests limits for brain reserve. The current study found that those with higher burden reported 
increased depression over time, regardless of level of education. This is consistent with 
Sternberg’s concept of passive brain reserve in that the reserve is protective until enough assault 
due to vascular factors overwhelms the protection of reserve. Brain reserve postpones, but does 
not preclude, the development of depression symptoms for elders with high CVB. 
The finding that elders with fewer symptoms at baseline tended to have greater education, 
and experienced a greater increase in depressive symptoms throughout the course of the study 
suggests two possible interpretations.  One explanation may be that less-educated respondents, 
with greater depression symptoms at baseline, were closer to a ceiling on the CESD instrument 
used in this study.  This is unlikely, however, given that group means suggest mean levels of 
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depressive symptoms far from the measure’s maximum score.  A more likely, and theoretically-
consistent explanation of this finding is that those with lower levels of depression at baseline, 
predominantly those with low CVB and comparably more education, are later in experiencing 
the normative late life increase in depression symptoms described by Teachman (2006).  By 
contrast, the apparent plateau in depressive symptom development observed among those with 
greater symptoms at baseline, those with greater CVB and less education, may reflect a later 
point on this normative depression curve.  
These results suggest several opportunities for further research.  Specifically, it is known 
that educational quality relates to neuropsychological test performance (Manly, Jacobs, Touradji, 
& Small, 2002); however, there are no measures of educational quality in the HRS data. Quality 
of education may better predict depression (and in fact, cognitive functioning) in late life than 
years of education. Finally, as the HRS lacks information on the severity of CVB indicators, this 
study could not determine the effect of disease severity on the development of depression 
symptoms over time. Despite these limitations, the findings from this study suggest that CVB 
and education are associated with depression in late life. Future work may develop on these 
findings to examine how CVB interacts with other variables such as depression symptoms to 
predict the incidence of, or time to, death among the older-old. 
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CHAPTER 3 
Successful Aging and Longevity in Older Old Women: 
The role of Depression and Cognition 
Abstract 
Based in successful aging theory and terminal cognitive drop research, this paper investigates 
cerebrovascular burden (CVB), depressive symptoms and cognitive decline as threats to 
longevity.  A subsample of stroke-free women over the age of 80 was identified in the Health 
and Retirement Survey (years 2000-2008).  Mortality at 2, 6 and 8 year intervals was predicted 
using CVB (diabetes, heart disease, hypertension), depressive symptoms (Center for 
Epidemiological Studies Depression Scale) and cognitive decline (decline of 1 standard 
deviation or more on the 35-point Telephone Interview for Cognitive Status over 2 years).  At 
most waves (2002, 2004, 2006) mortality was predicted by CVB, depressive symptoms and 
cognitive drop measured 2 years prior.  CVB and depressive symptoms at the 2000 wave 
predicted mortality at 6 and 8-years.  Older women with the greatest longevity had low CVB, 
robust cognitive functioning and few depression symptoms, supporting successful aging theory 
and terminal cognitive drop. 
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Introduction 
Rowe and Kahn (1997) proposed criteria for successful aging comprised of avoidance of 
disease, maintenance of high cognitive and physical function, and sustained engagement in social 
and productive activities.  This model grew from highly prolific MacArthur Foundation Study of 
Successful Aging, a $10 million, 10-year research effort led by Rowe and Kahn.  The objectives 
of this study, and the theoretical framework that grew from it, are to better understand risk 
factors for decline and to inform prevention efforts.  For instance, work drawn from this 
initiative concluded that pulmonary health relates to both gross motor and cognitive functioning 
in late life, suggesting this as an area for primary intervention in preserving late-life 
independence (Cook et al., 1995).  Drawing on the MacArthur Study data, Others have 
investigated modifiable risk factors for dementia, concluding that late-life depression may be a 
precursor of cognitive decline (Chodosh, Kado, Seeman, & Arun, 2007). Still other work based 
in this study found that older adults who frequently felt useful to others had lower rates of 
disability and mortality than less-engaged elders, emphasizing the importance of social 
engagement and productive activities (Greuenewald, Karlamangla, Greendale, Singer, & 
Seeman, 2007).  While support for this theory of successful aging has been mixed (Holstein & 
Minkler, 2003; Strawbridge, Wallhagen, & Cohen, 2002), it provides a useful framework for 
examining longevity. This paper will examine whether the Rowe and Kahn successful aging 
variables are each independently related to longevity.  In the current paper we chose to examine 
this theory in older old women over 80 years. Women constitute a majority of all older adults 
over 80, but more importantly, they are more likely than men to experience disability and to live 
more years with disability than men (Arber & Cooper, 1999).  Geriatric syndromes such as 
cardiovascular disease, cognitive decline and depression compromise functional independence 
more with increasing age(Rosso et al., 2011).  Age 80 represents a point when medical treatment 
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planning for elders should be re-evaluated given the escalating risks associated with these 
comorbidities. 
Behavioral factors as defined in this paper include psychological aspects of functioning 
that can be measured through self-report or performance-based assessment, such as mood and 
cognitive functioning (ie: depression and cognition).  Important behavioral factors such as 
cognition and depression represent major risk factors for disability, often preceding disability 
(Bruce, Seeman, Merrill, & Blazer, 1994) and possibly reducing longevity. Serious disability, 
especially mobility loss, has been linked to reduced survival (Hirvensalo, Rantanen, & 
Heikkinen, 2000). Identifying behavioral factors that hasten disability onset may then lead to 
improved models of integrated care.  Behavioral factors such as depression and cognitive decline 
may best be understood when integrated with chronic disease, especially those that enhance 
vascular risk.   
Though Rowe and Kahn interpreted “avoidance of disease” broadly, vascular disease is 
particularly significant to healthy aging as these chronic conditions (e.g. hypertension, atrial 
fibrillation, diabetes) gradually compromise adaptive resources. Neural network functioning is 
broadly compromised by the effect of vascular disease on cerebral tissue, termed cerebrovascular 
burden (CVB).  CVB is also associated with higher stroke risk, cardiac disease and sensorimotor 
impairment.  Moreover, high CVB hastens the manifestation of clinically significant cognitive 
impairment, regardless of the specific etiology of cognitive decline (eg: normative aging, 
Alzheimer’s disease, Parkinson’s disease, vascular dementia) (Flicker, 2010).  Elders with high 
CVB tend to have less prefrontal white matter volume, more white matter hyperintensites, and 
comparably impaired executive functioning (Raz et al., 2003).  Considerable evidence also exists 
that CVB also contributes to the development of late-life depression symptoms (Coffey et al., 
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1990; Sneed et al., 2008).  Thus in addition to being a broad measure of physical health in the 
Rowe and Kahn model, inclusion of CVB will distinguish variance in mortality risk directly 
related to this variable, thereby providing a more stringent test of how depression and cognition 
independently relate to longevity. 
Successful aging theory identifies sustained engagement in social and productive 
activities as central to healthy aging.  Clinical depression throughout the lifespan is characterized 
by reduced enjoyment in activities and decreased social engagement. As such, depression 
symptoms in late life represent a significant barrier to successful aging based on this 
interpretation. Generally speaking, more depression symptoms translate to poorer health 
outcomes.  For instance, people experiencing depression are at greater risk of a first heart attack 
(Glassman & Shapiro, 1998), stroke (Bos et al., 2008; Larson et al., 2001), cancer (Penninx, 
Buralnik, et al., 1998), worse health outcomes after controlling for cardiovascular risks 
(Glassman & Shapiro, 1998) and higher mortality (Arfken et al., 1999).  Depression in later life 
was found to be a significant risk factor for death.  Mehta et al (Mehta et al., 2003) reported that 
in a large sample of community-dwelling elders, mortality was significantly predicted by both 
number of depressive symptoms and performance on a measure of cognitive functioning. 
Similarly, it was reported that in a sample of older patients with debilitating or chronic medical 
diagnoses, after controlling for age, comorbidity and illness severity, functional impairment and 
cognitive functioning, depressed respondents were 34% more likely to die over three years 
(Covinsky et al., 1999).  In a large (N=3065) Dutch sample of individuals between the ages of 55 
and 80, depression was identified as a significant risk factor for death over four years. However 
the strength of this effect was partially eroded by the addition of other variables such as chronic 
disease, smoking and physical inactivity(Penninx, Geerlings, et al., 1999).   
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The third domain of successful aging theory identifies preservation of cognitive and 
physical functioning as critical to successful aging.  Cognitive impairment limits quality of life 
by reducing the capacity for meaningful work and social interaction (Missotten et al., 2008), and 
rapid loss of cognitive faculties often suggests medical decline with a heightened mortality risk 
(Penninx, Geerlings, et al., 1999; Riegel & Riegel, 1972).  Terminal cognitive drop is identified 
as an accelerated loss of cognitive functioning preceding death (Riegel & Riegel, 1972), by 
contrast to terminal decline which is a linear decline function preceding death(Palmore & 
Cleveland, 1976).  A review from 2002 concluded that, largely because testing terminal drop 
theory requires a repeated-measures design, limited data existed supporting this theory 
(Bosworth & Siegler, 2002).  Since this review several longitudinal studies have been published , 
including a recent study concluding that elders with sharp declines on the Mini Mental State 
Exam(Folstein, Folstein, & McHugh, 1975), a brief cognitive screening measure, experienced 
more activity of daily living (ADL) disability and higher mortality rates than elders with more 
stable scores (Yaffe et al., 2010).  While estimates of the temporal relationship between terminal 
drop and death vary, recent research identified evidence of terminal drop at a mean of 42 months 
before death (R. S. Wilson et al., 2007) in a large sample of dementia-free elders.  These 
estimates are roughly similar to the original estimates of about 5 years reported by Riegel et al 
(1972).  Similarly, past work drawing on the Health and Retirement Survey (HRS) data 
identified a relationship between cognitive impairment and mortality over a 2-year interval 
(Langa et al., 2008); however, this study evaluated cognitive decline cross-sectionally and did 
not include other markers of decline such as CVB or depression.  Of note, Langa et al reported 
evidence of compression of cognitive morbidity; elders with moderate or severe cognitive 
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impairment in 2002 had greater risk of death over 2 years than those with similar levels of 
impairment in 1993. 
Comorbid cognitive impairment and depressive symptoms suggest particularly high risk 
of death (Arfken et al., 1999; Mehta et al., 2003); however, these studies evaluated cognitive 
functioning cross-sectionally.  While impairment on cognition measures suggests decline from 
demographically-representative norms, the concept of terminal cognitive drop specifies rapid 
loss of cognitive functioning over a brief period of time.  Relatively few studies relating 
cognition and longevity evaluate how decline over brief periods relates to longevity, and even 
fewer investigate whether depression and cognitive decline are independent predictors of 
mortality.  Because cognition and mood, domains in which impairment may be most evident to 
family and medical practitioners alike, tend to be interrelated in late life (Bielak, Gerstorf, Kiely, 
Anstey, & Luszcz, In Press; Mast, Yochim, et al., 2004), it is important to distinguish the 
individual relationships of these variables with longevity. 
Objectives of the Present Study 
This investigation seeks to examine whether all three domains of Rowe and Kahn’s 
successful aging paradigm independently predict longevity in a large sample of stroke-free 
women over the age of 80.  In particular, this study emphasizes two behavioral domains that are 
of particular relevance in clinical settings – depression and cognitive decline. This theoretical 
orientation, based on a broad reading of the literature, posits that elders with few depression 
symptoms and preserved cognitive functioning will experience greater longevity.  In addition to 
CVB, other health variables such as self rated health and Body Mass Index (BMI) will be 
included in order to control for general health. The model proposed predicts that both depression 
and cognitive decline will predict mortality in this sample.  Hypothesis 1 looks at survival across 
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the entire study period of 8 years, whereas hypothesis 2 examines proximate predictors of death 
across 2-year intervals. 
Hypothesis 1: Physical health, depressive symptoms and cognitive decline at baseline 
(2000 wave) will all be independent predictors of longevity conceptualized as survival across the 
entire 8-year study period. 
Hypothesis 2: Incidence of death at each wave (2002, 2004, 2006 and 2008) will be 
predicted by CVB, cognitive decline and depressive symptoms at the previous wave. 
Method 
Sample 
 The Health and Retirement Survey (HRS) is a prospective cohort study conducted by the 
University of Michigan with support from the National Institute on Aging. The first wave of the 
HRS occurred in 1992 with a 51 to 61 year-old cohort and was merged with the older (70 years 
and older) Asset and Health Dynamics of the Oldest Old Study (AHEAD) cohort in 1998. Two 
additional cohorts were added in 1998 to fill in the gaps between these two groups. Briefly, the 
HRS is a multistage probability cohort sample of U.S. households. Further details on the HRS 
design and methods have been previously published (Heeringa & Conner, 1995).  
 The present study utilized the Health and Retirement Survey (HRS) that was prepared by 
the RAND Center for the Study of Aging (RAND HRS).  The selected portion of this publically-
available, longitudinal dataset includes five waves at two year intervals from 2000 through 2008 
(waves 5 through 9).  Inclusion criteria included age over 80 years at the first wave and female 
sex.  This study made use of the 1998 TICS score to identify incidence of cognitive decline from 
1998 to 2000.  Because stroke is associated with highly variable cognitive performance, 
participants with history of stroke prior to 1998 were excluded.  Respondents who were unable to 
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complete survey materials at the 1998 data collection were also excluded as missing data would 
have precluded calculation of 1998-2000 cognitive change scores.  This data set is 
demographically representative of the female US population over age 80. 
Measures 
Medical Data 
Medical data (hypertension, diabetes, history of heart disease, height, weight) and 
lifetime history of smoking was collected by self-report.  CVB was identified as the number of 
cerebrovascular risk factors (hypertension, diabetes, history of heart disease) reported creating a 
score ranging from 0 to 3. 
Depressive Symptoms 
A shortened, 8-item form of the original Center for Epidemiological Studies Depression 
Scale (CESD) was used to evaluate depression (Radloff, 1977).  Six of the eight items are 
negatively worded and two are positively worded.  Participants are asked to respond “yes” or 
“no” to each item (‘was depressed,’ ‘everything was an effort,’ ‘sleep was restless,’ ‘was happy,’ 
‘felt lonely,’ ‘enjoyed life,’ ‘felt sad,’ ‘could not get going’) that occurred within the preceding 
week.  Scores ranged from 0 to 8 with higher scores indicating greater depressive symptoms.  
Using HRS data, the reliability of the 8-item CESD measure was adequate, with Cronbach’s 
alpha ranging from .81 to .83 between waves(Steffick, 2000).  High validity, and symptom 
dimensions similar to those in the longer 20-item CESD have been demonstrated using these 8 
items (Steffick, 2000; Wallace et al., 2000).  The CESD is broadly used in the epidemiological 
study of late-life depression (Beekman et al., 1997).  While the CESD literature describes a 
clinical cutoff that can be used to distinguish respondents with probable depression(Steffick, 
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2000), this measure was used as a semi-continuous variable representing the full range 
depressive symptoms in this population sample . 
Cognitive Functioning 
 The HRS data includes a brief standardized 35-point measure of cognitive functioning 
that was developed for remote screening of cognitive disorders based on the Telephone Interview 
for Cognitive Status (Brandt et al., 1988).  It includes indices of orientation, concentration, short-
term memory, mathematical skills, praxis and language and has a maximum score of 35 points 
(observed range: 0-35) with higher scores reflecting better functioning .    This instrument has a 
Cronbach’s alpha of .69 and past work has identified factors reflecting mental status and 
memory(Herzog & Wallace, 1997).   The TICS has demonstrated high test-retest reliability and 
is generally sensitive to cognitive impairment (Brandt et al., 1988; Desmond et al., 1994; 
Järvenpää et al., 2002; Welsh et al., 1993).  For all of the following models cognitive decline was 
identified as a decrease in TICS score from one wave to the next wave of more than one standard 
deviation (6.1 points) based on baseline data. 
Self-Rated Health 
 Self-rated health change was measured with a single question assessing the respondents’ 
perception of change in health since the last data collection 2 years prior.  Change in self-rated 
health was assessed with the question, “Compared to your health when we talked with you in 
[last wave] would you say that your health is better now, about the same, or worse?”  Response 
options included “much better,” “somewhat better,” “same,” “somewhat worse,” “much worse,” 
comprising a 5-point scale.  This variable was included as a semi-continuous measure. 
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Statistical Methodology 
 Binary logistic regression was performed to model the likelihood of death between 
baseline (2000) and either 2006 or 2008 as a function of demographics, cognitive function, CVB 
and depression.  While the study spans the years 2000-2008, the logistic regression using 2006 as 
an end-point was included as closer to half the sample had died at this wave, thereby optimizing 
the statistical power of the model.  Variables were entered blockwise with age, years of 
education, and body mass index (BMI) entered in the first block.  The second block included 
CVB as reported in the 2000 wave.  The third block included the self-rated health change 
variable at the 2000 wave.  The fourth block included CESD score at the 2000 wave and a 
variable reflecting incidence of decline greater than 1 standard deviation (>6 points) on the TICS 
between the 1998 and 2000 waves. 
 To better track the relationship between TICS score decline, mood and longevity over the 
course of the study, four additional logistic regression models were computed.  In the first, 
incidence of death in 2002 was predicted using 2000 CVB, the 2000 CESD score and the index 
reflecting a drop in TICS score between 1998 and 2000 exceeding 1 standard deviation.  The 
second model predicted death in 2004 based on CVB in 2002, CESD score in 2002 and 
incidence of decline in TICS score of more than 1 standard deviation between 2000 and 2002.  
The third and fourth models predicted death in 2006 and 2008 using similar predictors, 
respectively. 
Results 
 Of the 1368 respondents who met criteria at the 1998 wave, 1186 were living at the 2000 
wave.  Of these, 417 were living at the 2008 wave representing a 64.8% mortality rate over this 8 
year period.  The sample at the 2000 wave is described in Table 3.1.  The mean age was 85.6 
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years (SD=3.8).  On average, respondents had 11 years of formal education (SD=3.4).  The mean 
BMI at baseline was 24.4 (SD=4.9).  The average number of cerebrovascular risk factors 
reported was 1 (SD=0.8).  The mean CESD score was 2.1 (SD=2) suggesting a low rate of 
depressive symptoms in this population.  The mean score on the 35 TICS measure was 18.1 
(SD=5.9).   
As can be seen in table 3.2, CVB and depressive symptoms were significant predictors of 
mortality between 2000 and 2006. In addition, age, and BMI were also significant predictors. 
Cognitive decline and self-rated health showed a trend toward being significant predictors. A 
slightly different picture emerged with respect to 2008 outcomes.  CVB was a significant 
predictor of mortality, and again BMI and age also predicted mortality. Depressive symptoms 
showed a trend toward significance while self-rated health was not a significant predictor. 
Cognitive decline between 1998 and 2000 was not a significant predictor of mortality at the 2008 
wave. Overall, the logistic regressions over 6 and 8 years provided partial support for applying 
Rowe and Kahn’s successful aging model to longevity. 
 Shown in Table 3.3, four additional logistic regressions predicting death in 2002, 2004, 
2006 and 2008 were completed to better understand the relationship between CVB, mood, 
cognitive change and longevity over brief periods of time.  CESD and TICS scores are 
unavailable for many participants, primarily for reasons of incapacity.  As a result of listwise 
deletion caused by absent data on these predictor variables, these four logistic regression 
analyses included 69% (2002), 61% (2004), 54% (2006), and 43% (2008) of respondents who 
died, respectively.  As described in Table 3, CVB significantly predicted mortality in the 2002, 
2004 and 2008 waves.  CESD score was a significant predictor of death in the 2002 and 2004 
waves.  Decline in TICS score over 2 years of more than 1 standard deviation significantly 
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predicted incidence of death in 2004 and 2008 and showed a trend toward significance in 2002 
(p=.088). 
Discussion 
 The primary findings of the present research are that, among women over the age of 80, 
CVB, depressive symptoms and rapid cognitive decline (terminal drop) predict incidence of 
mortality over brief periods (2 years).  CVB significantly predicted 2-year mortality at 3 of 4 
waves, and depressive symptoms and cognitive decline significantly predicted mortality at 2 of 4 
waves.  Over long periods (6 or 8 years) mortality was significantly predicted by age, BMI, and 
CVB. Additionally, depressive symptoms significantly predicted mortality over 6 years and 
showed a trend toward significance in predicting mortality over 8 years.  Incidence of rapid 
cognitive decline was not a significant predictor of death over 6 or 8 years.  As demonstrated in 
the analyses predicting death over 2-year periods, rapid cognitive decline is a robust predictor of 
proximal death.  Together, these findings suggest that in addition to undermining quality of life 
and independence as described by Rowe and Kahn, sharp cognitive decline suggests high risk of 
imminent death.  Cognitive drop, even in the older old is a significant indicator of declining 
health and potentially shortened life. While it is well documented that cognitive abilities decline 
in those over 80(Dahle, Jacobs, & Raz, 2009), it is when declines are significantly above the 
norm when life expectancy is affected among the older old.  By contrast, many of those who died 
toward the end of this study had robust cognitive functioning at this baseline interval.  These 
results are consistent with past work describing the relationship between CVB, mood, cognitive 
decline, and longevity (Arfken et al., 1999; Mehta et al., 2003; Penninx, Geerlings, et al., 1999; 
Riegel & Riegel, 1972; R. S. Wilson et al., 2007; Yaffe et al., 2010). 
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 The present findings support and extend Rowe and Kahn’s (1997) successful aging 
theory by relating low CVB, relatively few depressive symptoms and preserved cognitive 
functioning, representing the three domains of successful aging theory, to greater longevity in 
this sample of older women.  In the present study, Rowe and Kahn’s formulation of successful 
aging is expanded from quality of life to length of life.  Heightened depression and rapid loss of 
cognition were significantly related to timing of death, and conversely robust functioning was 
related to longevity.  These findings underscore the significance of behavioral factors to the 
discussion of longevity.  Behavioral factors such as mood and gross cognitive functioning are 
basic characteristics of the individual patient, and these findings highlight the importance of 
subjective reports or clinician perceptions of decline in these areas, especially when working 
with older patients.  The finding that CVB predicts longevity broadly supports the large medical 
and epidemiological literature citing conditions such as heart disease, hypertension and diabetes 
as risk factors for death (discussed in Flicker, 2010). Our finding that depressive symptoms 
predict longevity corroborate significant past work on this subject (Arfken et al., 1999; Covinsky 
et al., 1999; Mehta et al., 2003; Penninx, Geerlings, et al., 1999).   
These findings are also consistent with the concept of terminal cognitive drop (Riegel & 
Riegel, 1972).  While some studies support the terminal cognitive decline effect over longer 
periods of time (Riegel & Riegel, 1972; R. S. Wilson et al., 2007; Yaffe et al., 2010), these 
findings support other research (Arfken et al., 1999; Mehta et al., 2003) that terminal cognitive 
drop theory can be applied over brief periods of time.  Additionally, most research supporting 
terminal cognitive decline relates mortality to impaired performance on cognitive measures, 
suggesting decline from an idiographic baseline and consequently discounting the time period 
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over which decline occurs.  By contrast, the present study contributes to the existing literature by 
testing this theory among older-old women using longitudinal data.   
 The primary limitation of the present study is that cognitive and mood data are not 
available for many respondents nearing death.  This data is absent largely for reasons of 
incapacity.  Consequently, it is likely that the relationship between depressive symptoms, 
cognitive decline and longevity is underrepresented by the present research.  Another limitation 
is the use of categorical self-reported CVB data.  However, use of such data is common in 
population-based samples and reasonable concordance values between self-reports of disease and 
medical chart reviews have been reported (Bush et al., 1989; Psaty et al., 1995).  Future research 
should build on the present finding by identifying relationships between markers of 
cerebrovascular health, depression and cognitive decline.  
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CHAPTER 4 
Vascular Depression: An Early Warning Sign of Frailty 
Abstract  
Objectives: Frailty is a common geriatric disorder associated with ADL impairment, 
hospitalization, and death.  Phenomenological evidence suggests that late-life depression (Katz, 
2004), particularly vascular depression, may be a risk factor for frailty and this study tests that 
hypothesis. 
Methods: We identified a sample of stroke-free women over the age of 80 from the Health and 
Retirement Survey.  Frail respondents experienced at least three of the following: wasting, 
exhaustion, weakness, slowness, and falls.  Respondents with vascular depression had both high 
cerebrovascular burden (at least two cerebrovascular risk factors) and depression, (score ≥ 3 on 
the 8-item CESD).  
Results: At baseline, the prevalence of frailty was 31.5%.  Over a 4-years the incidence of frailty 
was 31.8%.  After controlling for age, education, ADL and IADL functioning, arthritis, 
pulmonary disorders, cancer, and self-rated health, vascular depression significantly predicted 
new cases of frailty.   
Discussion: These findings suggest that vascular depression is a prodrome for frailty. 
 
Key Words: Frailty, Vascular Depression, Older Women 
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Introduction 
Research on frailty among older adults has increased over the past decade, both to define 
phenotypes and identify markers for future frailty (Fried et al., 2001; Varadhan et al., 2009). 
Frailty is clearly related to advanced age, heart dysfunction (Varadhan et al., 2009), subclinical 
vascular biomarkers (Newman et al., 2011), and being female (Fried et al., 2001). The clinical 
pathways that lead to frailty are poorly understood; our study attempts to increase knowledge of 
the underlying mechanisms of this common late-life syndrome by examining a specific pattern of 
medical comorbidity—vascular depression—and incorporating it into a model of other medical 
conditions and functional abilities to predict new-onset frailty cases in women over the age of 80. 
The co-occurrence of vascular diseases and depression may signal that if elders are 
treated by standard means, they will decline into frailty(Rosso et al., 2011), a syndrome that 
imposes a significant burden on the health-care system(Fassbender, Fainsinger, Carson, & 
Finegan, 2009). While frailty, comorbidity, and disability are distinct concepts(Fried, Ferrucci, 
Darer, Williamson, & Anderson, 2004), this study aims to increase our understanding of how 
vascular depression—which is a combination of particular medical comorbidities—and reported 
disability affect the incidence of frailty in older-old women. 
Frailty 
 Frailty is conceptualized as the combined effects of life stress that result in multisystemic 
dysregulation of homeostatic systems (Clegg, 2011; Fried et al., 2004).  Although there are 
multiple models of frailty, Fried’s (Fried et al., 2001) continues to be among the foremost 
(Clegg, 2011). In this model, frail individuals are described as having at least three of the 
following conditions: unintentional weight loss, exhaustion, weakness, slow walking speed, and 
low physical activity.  Fried (2001) reported that frailty is more common among women, Black 
elders, and those with lower education and income, relatively poor health, and greater medical 
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comorbidity and disability.  Frailty grows more common with increasing age; base rates range 
from 3% to 7% of individuals between ages 65 and 75 (Fried, 2003), and more than 30% for 
individuals in their 90s (Walston et al., 2002). Frailty is also associated with comparably poor 
subjective health evaluations, vascular disease (Barzilay et al., 2007; Fried et al., 2001), arthritis 
(Fried et al., 2001), greater heart rate variability (Varadhan et al., 2009), and insulin resistance 
(Barzilay et al., 2007).  Frail individuals experience decreased mobility and higher rates of 
impairment in performing activities of daily living (ADLs), hospitalization, and death (Fried et 
al., 2001; Lupon et al., 2008), making this syndrome a significant public health concern.   
Depression 
Vascular depression is defined as the increased prevalence of depression symptoms in 
late life resulting from high cerebrovascular burden (CVB; Alexopoulos et al., 1997a).  The 
vascular depression hypothesis has generated two complementary lines of research, both of 
which inform this discussion of vascular depression and frailty.  One uses neuroradiological data 
to describe the relationship between prefrontal subcortical white matter hyperintensities, which 
are typically attributed to CVB, and late-life depression symptoms (Sneed et al., 2008). Other 
studies, however, have reported no significant relationship between cerebral vascular change and 
depression (Rainer et al., 2006).  The second line of research approaches the relationship from a 
clinical perspective, relating the presence of multiple cerebrovascular risk factors (diabetes, 
hypertension, etc.) to development of depression symptoms in late life (Mast et al., 2008). This 
conceptualization of vascular depression is also not universally supported (Lyness et al., 1999).  
Nonetheless, both areas of vascular depression research generally support Alexopoulos’s 
hypothesis that affective functioning involves an elaborate network of fronto-striatal projections 
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(Drevets et al., 2008) and appears to be highly sensitive to microvascular insult (Sneed et al., 
2008). 
Katz (2004) discussed the numerous theoretical and phenomenological connections 
between depression and varying models of frailty.  He noted that white matter disease 
characterizes both late-onset depression and psychomotor deficits, which can be symptomatic of 
frailty. Katz did not, however, speculate as to whether vascular depression, as opposed to late-
life depression, is related to frailty. Andrew and Rockwood (2007) reported that psychiatric 
disease is four times more common among frail elders than among the most robust elders.  
Interpretation of these results is limited, however, by the use of cross-sectional data and the 
identification of psychiatric illness based on retrospective self-report.  Additionally, this study 
included CVB markers (hypertension, cardiac disease, and diabetes) as indicators of frailty, 
precluding analysis of these variables as risk factors for frailty.  Other work has related 
depression to various correlates and indicators of frailty, including fall risk (P. Thomas et al., 
2009) malnutrition (P. Thomas et al., 2009) which can lead to wasting, steep decline in strength 
(Rantanen et al., 2000), and deficits in ADL functioning and mobility (Penninx, Leveille, et al., 
1999).   
Vascular Depression and Disability as an Early Indicator of Frailty  
In this study, vascular depression was conceptualized as a prodrome for frailty.  As 
described above, vascular depression has a neurological basis. Katz (2004) theorizes that 
cerebrovascular disease that causes prefrontal white-matter hyperintensities and vascular 
depression may also lead to posterior white matter hyperintensities, resulting in characteristics of 
frailty such as falls, slowness, and weakness.  Recent findings of higher rates of cardiovascular 
disease and cerebral infarcts among frail elders support this hypothesis (Newman et al., 2011).  
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Accordingly, vascular depression may be a highly sensitive, clinically relevant indicator of 
global cerebral disease process and, in turn, a harbinger of subsequent frailty and mortality. 
However, this hypothesis has not been explicitly tested; neither Katz (2004) nor Newman (2011) 
examined whether vascular depression was a better predictor of frailty onset than either vascular 
disease without depression or depression without vascular disease.  
The objectives of this study were to (1) describe the prevalence of frailty in a sample of 
stroke-free women over the age of 80 and the incidence of new cases of frailty over 4 years, and 
(2) to test the hypothesis that vascular depression and disability predict frailty among older-old 
women. This study sought to examine whether vascular depression and disability predicted new-
onset frailty. To examine the specificity of vascular depression, we included as control variables 
other medical conditions (arthritis, pulmonary disease, and cancer) that are often related to 
disability.  
Method 
Sample 
 The Health and Retirement Survey (HRS) is an ongoing prospective multistage 
probability cohort study of U.S. households conducted by the University of Michigan with 
support from the National Institute on Aging (Heeringa & Conner, 1995). The first wave of the 
HRS occurred in 1992, with a 51- to 61-year-old cohort, and in 1998 was merged with the 70-
and-older cohort of the Asset and Health Dynamics of the Oldest Old Study. Also in 1998, two 
additional cohorts were added to fill the gap between the two groups.  
 Our study included HRS data drawn from the 1998 wave, when many participants were 
added to the study.  This sample included female respondents without history of stroke in 1998. 
Respondents were excluded if they were unable to independently complete survey materials 
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(e.g., the CES-D, a measure of depressive symptoms) at the 2000 wave.  This data set was 
otherwise demographically representative of the female U.S. population over age 80 and 
included 1139 respondents.  Complete frailty data was available at 2000 and 2004, so we 
included data drawn from these waves (waves 5 and 7) exclusively.  
Measures 
Frailty 
We measured frailty using Fried’s (2001) conceptualization of frailty as a phenotype. 
Due to differences between the HRS data and Fried’s model of frailty, we adapted the frailty 
index to include five symptoms: wasting, weakness, slowness, fatigue or exhaustion, and falls.  
The wasting criterion was met if a respondent reported loss of at least 10% of body weight over a 
2-year period.  The weakness criterion was met if they endorsed the question, “Because of heal th 
problems, do you have any difficulty with lifting or carrying weights over 10 pounds, like a 
heavy bag of groceries?” The slowness criterion was met if respondents answered in the 
affirmative to the question, “Because of a health problem, do you have any difficulty with 
getting up from a chair after sitting for long periods?”  The fatigue or exhaustion criterion was 
met if the respondent answered in the affirmative to the question, “Since we last talked with you 
in [the last wave], have you had any of the following persistent or troublesome problems: . . . 
severe fatigue or exhaustion?”  The falls criterion was met if the respondent answered in the 
affirmative to the question, “Have you fallen down in the past 2 years?”  While Fried’s criteria 
include low energy expenditure, this variable was not available in the HRS data.  Instead, the 
frailty phenotype was modified to include falls, which was found to be an indirect measure of 
energy expenditure (Montero-Odasso et al., 2011). None of these frailty items was drawn from 
the CES-D. Individuals who met at least three of the criteria were identified as frail. 
55 
 
 
 
Self-Reported Medical Conditions 
Medical data (hypertension, diabetes, history of heart disease, arthritis, pulmonary 
disorders, cancer) and lifetime history of smoking were collected by self-report.  Consistent with 
past work (Mast, Neufeld, et al., 2004; Mast, Yochim, et al., 2004; Yochim et al., 2003), 
respondents with high CVB were those with two or more cerebrovascular risk factors 
(hypertension, diabetes, cardiac disease, and history of smoking).  Hypercholesterolemia was not 
included because it was not reported in the data at every wave.  
Functional Independence 
The score for ADLs reflected how many of the following activities the respondent 
reported requiring assistance with: bathing, eating, dressing, walking across a room, and getting 
in or out of bed.  Scores ranged from 0 to 5.  Instrumental activities of daily living (IADLs) were 
measured by identifying which of the following the respondent required assistance with: using a 
telephone, taking medication, and handling money.  Scores ranged from 0 to 3. 
Self-Rated Health 
 Change in self-rated health was assessed with the question, “Compared to your health 
when we talked with you in [last wave], would you say that your health is better now, about the 
same, or worse?”  Response options were “much better,” “somewhat better,” “same,” “somewhat 
worse,” and “much worse,” comprising a 5-point scale. 
Depressive Symptoms 
A shortened, 8-item form of the original Center for Epidemiological Studies Depression 
Scale (CES-D) was used to evaluate depression (Radloff, 1977).  Six of the eight items are 
negatively worded and two are positively worded.  Participants are asked to respond “yes” or 
“no” to each item (“was depressed,” “everything was an effort,” “sleep was restless,” “was 
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happy,” “felt lonely,” “enjoyed life,” “felt sad,” “could not get going”), based on whether or not 
they had experienced it during the preceding week.  Scores ranged from 0 to 8, with higher 
scores indicating greater depressive symptoms.  Using HRS data, the reliability of the 8-item 
CES-D measure was adequate, with high Cronbach’s alpha (.81-.83; (Steffick, 2000).  The 8-
item CES-D has high internal consistency (α = .77) and validity (Steffick, 2000) and is broadly 
used in epidemiological studies of late-life depression (Beekman et al., 1997).  Citing the 
recommended interpretation of this measure (Steffick, 2000), CES-D scores ≥3 were interpreted 
to indicate probable clinical depression. 
Statistical Methodology 
 A variable representing clinically defined vascular depression was created in which 
respondents with neither high CVB nor probable depression were assigned a score of 0, 
respondents with either high CVB or probable depression were assigned a score of 1, and 
respondents with both high CVB and probable depression were assigned a score of 2.  Complete 
frailty data were reported in the 2000 and 2004 waves. Data in the 2000 wave were used to 
assess how variables of interest predicted the prevalence of frailty at baseline among all available 
respondents.  How these variables predicted the incidence of new frailty in 2004 was assessed by 
excluding respondents who were frail at the 2000 wave. 
Two chi-square tests of independence were completed that examined the prevalence of 
frailty at 2000 and the incidence of new frailty in 2004, using vascular depression as the single 
predictor.  A step-wise logistic regression was then performed to evaluate how demographic 
variables (age, years of education), ADLs, IADLs, arthritis, pulmonary disorders, cancer, change 
in self-rated health, and vascular depression (measured in 2000) predicted the prevalence of 
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frailty in 2000.  A second step-wise logistic regression was then performed to test how these 
indicators predicted incidence of new frailty in 2004.   
Results 
 Of 1139 respondents living at the 2000 data collection, 992 respondents completed 
baseline survey materials at the 2000 baseline, and complete data were available for 984 of these 
respondents.  These 984 respondents were included in the logistic regression predicting 
prevalence of frailty described below.  Of these, 310 were frail in 2000 (prevalence = 31.5%) and 
were excluded from the second logistic regression model that predicted incidence of frailty.  Of 
the remaining 674 respondents, 491 were still living in 2004 and complete data were available 
for 459 respondents.  The second logistic regression included these 459 respondents.  As shown 
in Table 4.1, the sample had a mean age at baseline (year 2000) of 84.53 years (SD=3.03) and 
11.24 mean years of education (SD=3.13).  The sample was predominantly White, and most 
respondents remained independent at baseline, as suggested by the relatively low levels of ADL 
and IALD impairment.  Of the 984 respondents included in the 2000 prevalence analysis, 32.8% 
had CES-D scores of at least 3—suggesting probable depression—and the mean CES-D score 
was 2.07 (SD=1.98).  Of the 459 respondents included in the 2004 incidence analysis, 22% had 
CES-D scores at the 2000 data collection that suggested probable depression; the mean 2000 
CESD score was 1.55 (SD=1.70). 
Over the 4-year course of the study, the incidence of frailty was 31.8% (n = 146).  Table 
4.2 displays prevalence rates in 2000 (all available respondents who met inclusion criteria) and 
frailty incidence rates in 2004 (excluding any respondents who were frail in 2000) among 
respondents at each level of the vascular depression variable. As can be seen in the Table frailty 
was most common among those with vascular depression. Indeed when compared to those with 
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either depression alone or vascular burden alone those with vascular depression were 
significantly more likely to be frail, both at baseline (X2=13.59, p<.001) and four years later 
(X2=5.77, p=.02). Interestingly, those with either depression or vascular burden were more likely 
than those without either to be frail both at baseline (X2=22.49, p<.001) and four years later 
(X2=5.55, p=.02).   
 Results of the first step-wise logistic regression describing frailty prevalence in 2000 are 
displayed in Table 4.3. At the 2000 wave, 31.5% of the sample was identified as frail.  Age, 
education, ADLs, IADLs, arthritis, pulmonary disorders, cancer, and self-reported health change 
in 2000 were included in the first step of the model.  In this first step, frailty was significantly 
predicted by age (β=.06, Wald=9.11, p=.003), ADLs (β=.641, Wald=57.89, p<.001), arthritis 
(β=1.09, Wald=30.47, p<.001), and change in self-rated health (β=.46, Wald=20.91, p<.001).  
The addition of the vascular depression variable substantively improved the model (X
2
=13.29, 
p<.001).  In the final prevalence model, frailty was significantly predicted by age (β=.06, 
Wald=9.52, p=.002), ADL disability (β=.60, Wald=49.61, p<.001), arthritis (β=1.05, 
Wald=28.18, p<.001), self-rated health change (β=.39, Wald=14.58, p=.001), and vascular 
depression (β=.41, Wald=26.68 p<.001).  This model had a sensitivity of .445 and specificity of 
.914.  Positive predictive value (PPV) was .704 and negative predictive value (NPV) was .782.  
The incremental validity using the PPV was .389 and .097 using the NPV. 
 Results of the second step-wise logistic regression describing frailty incidence in 2004 
are displayed in Table 4.4. Variables were entered in the same manner as the first logistic 
regression. In the first step of the logistic regression, only ADLs (β=.50, Wald=7.85, p≤.01) and 
self-reported health change (β=.69, Wald=15.89, p≤.001) significantly predicted incidence of 
frailty in 2004.  In the second step, the addition of the vascular depression variable significantly 
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improved the overall model (X2=9.14, p=.003).  In this final model, ADLs (β=.49, Wald=7.21, 
p≤.01), self-rated health change (β=.65, Wald=13.53, p≤.001), and vascular depression (β=.49, 
Wald=9.12, p≤.01) emerged as significant predictors of frailty in 2004.  This second model had 
low sensitivity (.27) but high specificity (.95), and both good PPV (.70) and NPV (.74).  This 
model had incremental validity of .384 using the PPV and .054 using the NPV. 
Discussion 
 Our first finding is that the prevalence of frailty in this demographically representative 
sample of stroke-free women over the age of 80 was 31.5%.  Of the respondents who were not 
frail at baseline, the incidence of frailty after 4 years was 31.8%.  The second finding was that 
vascular depression—characterized as the co-occurrence of high CVB and clinically significant 
depression symptoms—predicted prevalent and incident frailty in a sample of women over 80. 
Importantly, those with vascular depression had higher rates of frailty than either those with 
depression alone or vascular burden alone.  The prevalence and incidence estimates are generally 
consistent with other estimates of frailty frequency in this demographic (Affairs, 1990; Walston 
et al., 2002).  Katz predicted that depression precedes frailty in late life (Katz, 2004).  The 
findings of the current study support this hypothesis and build on Katz’s work by demonstrating 
that a specific subtype of depression (i.e., vascular depression) is a better predictor of new-onset 
frailty. 
 In addition to vascular depression, ADL disability was a significant predictor of frailty 
onset.  Fried et al. (Fried et al., 2004) distinguished the concepts of comorbidity, disability, and 
frailty, while noting that in aging populations, these syndromes often overlap.  The present 
findings support this conceptualization, and extend the model by suggesting that certain 
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combinations of comorbidity and disability have a temporal ordering with frailty. For instance, 
frailty was extremely uncommon among those without ADL disability and vascular depression.   
The primary limitation of the study is the use of self-reported health data and lack of 
clinical evaluations for depression.  However, this practice is common in population-based 
samples, and adequate agreement between self-reports of disease and medical chart reviews has 
been reported (Bush et al., 1989; Psaty et al., 1995).  A second limitation of this analysis is that 
the high rate of mortality in this sample resulted in listwise deletion of the most medically 
vulnerable elders.  Consequently, it is probable that these findings underestimate the strength of 
the relationship between disability, vascular depression, and frailty.  Future research may explore 
how vascular depression and frailty relate to longevity among the older-old. 
The findings of this study significantly extend our understanding of the impact of 
vascular depression as a pathway to frailty. As medical practice with older patients trends toward 
collaborative care, depression is emerging as a critical clinical indicator of decline in medical 
functioning.  While vascular depression is conceptualized as having a neurological basis, some 
have described empirically supported interventions for this syndrome (Alexopoulos et al., 2011; 
Mackin & Arean, 2005), suggesting that vascular depression may be a modifiable risk factor for 
frailty, even in late life.  Other interventions suggested by these findings include addressing CVB 
much earlier, thereby reducing the deleterious effects of hypertension, diabetes, and cardiac 
disease.  
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CHAPTER 5 
Vascular Depression and Frailty: A compound threat to longevity among older-old women 
Abstract 
Vascular depression theory posits that high cerebrovascular burden predisposes, precipitates and 
perpetuates development of depression symptoms in late life (Alexopoulos et al., 1997b).    
Building on past work suggesting that vascular depression is a prodrome for frailty (Paulson & 
Lichtenberg, 2011), this paper tests a theoretical framework that vascular depression symptoms 
are an early marker of a broader pattern of decline characterized by more frailty symptoms and 
shortened lifespan.  The specific hypothesis tested in this model is that depression predicts 
mortality through frailty.  A 5-level vascular depression variable was based on CES-D scores and 
number of cerebrovascular risk factors.  Frailty was measured as a semi-continuous variable 
based wasting, slowness, weakness, fatigue and falls (score 0-6).  Vascular depression and frailty 
symptoms were modeled using slope and intercept terms.  Mortality was modeled using a 
discrete-time survival term.  The data supported the proposed model (RMSEA=.051; CFI=.971; 
X2=429.27, p<.001).  Higher vascular depression symptom slope predicted higher frailty 
symptom slope (β= .23, p=.02).  Higher vascular depression intercept values significantly 
predicted higher frailty intercept term values (β=.42, p<.001), which predicted probability of 
mortality (β=.07, p=.04).  Additionally, vascular depression symptoms significantly predicted 
mortality through frailty symptoms (β=.03, p=.04).  Our results support the proposed theoretical 
framework and suggest that vascular depression symptoms are associated with a clinical 
trajectory including more frailty symptoms and shorted remaining lifespan.  This finding 
supports integrated care for geriatric patients and suggests specific targets for intervention with 
older patients experiencing vascular depression symptoms. 
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Introduction 
Up to 30% of elders die with, or because of, frailty (Fassbender et al., 2009; Paulson & 
Lichtenberg, 2011) and frail elders’ need for prolonged long-term care makes this syndrome 
among the most costly causes of death (Fassbender et al., 2009).  The growing literature on 
frailty identifies this syndrome as a marker of functional decline, physiological dysregulation, 
and heightened mortality risk (Fried et al., 2001; Varadhan et al., 2009). The recent trend toward 
collaborative care and treatment of medical syndromes is associated with improved patient 
outcomes (Boult et al., 2008), greater satisfaction for medical professionals (Sylvia et al., 2008), 
and reduced health-care costs (Brownlee, 2007; Sylvia et al., 2008), especially for vulnerable 
aging patient populations.  Women constitute a growing majority of adults over age 80 and live 
more years with disability than do men.  Improving our understanding of broad patterns of 
decline and preserving independence, especially in this at-risk population, is a priority in our 
national efforts to optimize use of healthcare resources.  
We evaluated a theoretical framework that relates the symptoms of vascular depression, 
frailty, and earlier mortality to better understand the pathways that lead to frailty among older-
old women.  Our objectives were to describe the temporal relationship and connections between 
vascular depression symptoms, frailty symptoms, and mortality in a sample of stroke-free 
women over the age of 80.  
In the proposed model, high cerebrovascular burden (CVB), which is characterized by 
disorders such as hypertension, diabetes, and cardiac disease, is viewed as a threat to long-term 
adaptive functioning.  For example, even healthy adults with high CVB have smaller prefrontal 
cortex and white matter volumes and more white matter hyperintensities (Raz et al., 2003).  High 
CVB hastens the presentation of cognitive impairment resulting from all causes (Flicker, 2010).  
63 
 
 
 
Older adults with high CVB also demonstrate exaggerated age-related declines in domains such 
as psychomotor speed and working memory (Dahle et al., 2009).  Elders with high CVB and 
concomitant white matter hyperintensities are also at greater risk for mood decline, termed 
vascular depression (Coffey et al., 1990; Sneed et al., 2008).   
Vascular depression theory (Alexopoulos et al., 1997b) posits that high CVB 
compromises neurological functioning and that, as a result, depression symptoms develop.  
Consistent with vascular depression theory, depressed elders are more likely to have prefrontal 
white matter hyperintensities (Coffey et al., 1990; Sneed et al., 2008) and relatively impaired 
cognitive functioning on measures of executive functioning (Mast, Yochim, et al., 2004).  
Vascular depression theory has produced two complementary lines of research. One describes 
how CVB-mediated neurological changes—and prefrontal white matter hyperintensities in 
particular—predict higher rates of depression among elders (Sneed et al., 2008).  The other 
describes clinically defined vascular depression, in which greater depression symptoms are 
predicted by comorbidities such as diabetes, hypertension, and cardiac disease (Mast, Neufeld, et 
al., 2004; Yochim et al., 2003).  While results have been mixed for both neuroradiological 
(Rainer et al., 2006) and clinical research (Lyness et al., 1999), both approaches generally 
support vascular depression theory.  Of particular relevance to this synthesis, elders with high 
CVB and depression have much higher mortality rates than their healthier counterparts 
(Lavretsky et al., 2010). 
The proposed model hypothesizes that vascular depression symptomatology is one entry 
point into the cycle of frailty.  Broadly speaking, frailty symptoms can be viewed as the 
combined effects of life stress that results in multisystemic dysregulation of homeostatic systems 
(Clegg, 2011; Fried et al., 2004). Numerous models of frailty exist, including Fried’s 
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specification of wasting, weakness, slowness, fatigue, and low activity. We chose this model, 
which is commonly used in the literature, for this study.  Fried (2001) reported that frailty is 
more common among women, Black elders, medically compromised individuals, those with 
disabilities, and those with lower education and income, and becomes increasingly prevalent in 
late life. As described by Katz (2004), both late-life depression and frailty are characterized by 
white matter hyperintensities, in addition to other numerous phenomenological and theoretical 
similarities. 
Recent work by our group has shown that vascular depression symptoms can be an early 
warning sign of frailty (Paulson & Lichtenberg, 2011). Although both vascular depression and 
frailty symptoms have been associated with heightened mortality rates (Cawthon et al., 2007; 
Fried et al., 2001), the model we propose posits that vascular depression symptoms are an earlier 
indicator of a broader pattern of decline that is subsequently characterized by higher rates of 
frailty symptoms and mortality.  Cerebrovascular risk factors place an enormous burden on the 
physical—and especially the neurological—integrity of the oldest old.  In our proposed model, 
vascular depression symptoms are an early indicator of the decline of brain integrity, with frailty 
symptoms emerging later as neurological damage continues to accrue. 
The proposed model describes a dynamic process that develops over a period of years.  
Accordingly, detection of these effects requires a longitudinal research design that uses large-
scale cohort panel data, such as the Health and Retirement Study (HRS).  The hypothesis tested 
in this paper posits that vascular depression will predict frailty, and will predict mortality 
indirectly through frailty in a sample of stroke-free women over the age of 80. 
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Method 
Sample 
 The HRS is a National Institute on Aging–supported prospective, multistage cohort study 
of U.S. households (Heeringa & Conner, 1995).  The HRS data includes four smaller samples 
consisting of (a) respondents from the original (1992) HRS who were aged between 51 and 61 
that year; (b) the Asset and Health Dynamics of the Oldest Old study, which included 
participants over age 70 and was merged with the HRS in 1998, and (c) two additional samples 
selected in 1998 to better represent the population of retired adults in the United States.  Most 
HRS survey data are collected at 2-year intervals. 
 A subsample of HRS respondents consisting of women 80 years and older in 1998 
formed the baseline for this study.  Respondents were excluded if, in 1998, they reported a 
history of stroke or were unable to independently respond to survey materials (e.g., the CES-D, a 
measure of depressive symptoms). We then incorporated data from the six biennial waves (1998-
2008). 
Measures 
Self-Reported Medical Conditions 
Medical data (hypertension, diabetes, history of heart disease) and lifetime history of smoking 
were collected by self-report.  Hypercholesterolemia was not included, because it was not 
reported in the data at every wave.  Vital status was identified at each wave.  In the case of 
deaths, the exact date within the 2-year period was not known. 
Depressive Symptoms 
Depression was measured using a shortened, 8-item form of the original Center for 
Epidemiological Studies Depression Scale (CESD; Radloff, 1977).  Six of the eight items are 
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negatively worded and two are positively worded.  Participants are asked to respond “yes” or 
“no” to each item (“was depressed,” “everything was an effort,” “sleep was restless,” “was 
happy,” “felt lonely,” “enjoyed life,” “felt sad,” “could not get going”), based on whether or not 
they had experienced it during the preceding week.  Scores ranged from 0 to 8, with higher 
scores indicating greater depressive symptoms.  Using HRS data, the reliability of the 8-item 
CES-D was adequate, with high Cronbach’s alpha (.81-.83; (Steffick, 2000).  The 8-item CES-D 
has high internal consistency (α = .77) and validity (Steffick, 2000) and is broadly used in 
epidemiological studies of late-life depression (Beekman et al., 1997).  Recommended clinical 
cutoffs for this measure suggest interpreting CES-D scores ≥3 (Steffick, 2000) as indicative of 
probable clinical depression. 
Vascular Depression Symptoms 
 In keeping with past work (Paulson & Lichtenberg, 2011) depression symptomatology 
and CVB were integrated to form a single variable representing vascular depression 
symptomology.  As displayed in Figure 5.1, respondents with 0 or 1 cerebrovascular risk factor 
(CVRF) and a CES-D score of 0 or 1 were assigned a score of 1 (description: very healthy).  
Those with 1 CVRF and CES-D scores of 1 or 2 were assigned a score of 2 (description: 
healthy), as were those with 0 CVRFs and a CES-D score of 2.  Respondents with 2 or more 
CVRFs or a CES-D score ≥3 were assigned a score of 3 (description: high CVB or probable 
depression).  Respondents with 2 or more CVRFs and CES-D scores of 3 or 4 were assigned a 
score of 4 (description: mild vascular depression symptoms).  Those with more than 2 CVRFs 
and CES-D scores ≥5 were assigned a score of 5 on the vascular depression variable 
(description: moderate to severe vascular depression symptoms). 
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Self-Rated Health 
 Self-rated health was measured by comparing self-rated health reports (1=excellent, 
2=very good, 3=good, 4=fair, 5=poor) at adjacent time periods.  Positive values indicate health 
deterioration over a 2-year period.  Negative values suggest improved health. 
Functional Independence 
 Activities of daily living (ADLs) were measured using five criteria: bathing, eating, 
dressing, walking across a room, and getting in or out of bed.  Instrumental activities of daily 
living (IADLs) were measured using three criteria: using a telephone, taking medication, and 
handling money.  Scores on both indices indicate the number of items the respondent reported 
experiencing difficulty completing independently.  Higher scores indicate greater disability. 
Frailty 
We measured frailty symptomatology based on Fried’s (2001) conceptualization. Due to 
differences between the HRS data and Fried’s model of frailty, we adapted the frailty index to 
include five symptoms: wasting, weakness, slowness, fatigue or exhaustion, and falls.  The 
wasting criterion was met if a respondent reported loss of at least 10% of body weight over a 2-
year period.  The weakness criterion was met if she endorsed the question, “Because of health  
problems, do you have any difficulty with lifting or carrying weights over 10 pounds, like a 
heavy bag of groceries?” The slowness criterion was met if respondents answered in the 
affirmative to the question, “Because of a health problem, do you have any difficulty with 
getting up from a chair after sitting for long periods?”  The fatigue or exhaustion criterion was 
met if the respondent answered in the affirmative to the question, “Since we last talked with you 
in [the last wave], have you had any of the following persistent or troublesome problems: . . . 
severe fatigue or exhaustion?”  The falls criterion was met if the respondent answered in the 
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affirmative to the question, “Have you fallen down in the past 2 years?”  While Fried’s criteria 
include low energy expenditure, this variable was not available in the HRS data.  Instead, the 
frailty symptom list was modified to include falls, which was found to be an indirect measure of 
energy expenditure (Montero-Odasso et al., 2011). None of the frailty items was drawn from the 
CES-D. This frailty index was used as a semicontinuous variable.  Complete frailty data were 
available at the 2000, 2004 and 2008 waves. 
 
Statistical Methodology 
Our primary objective was to test the described theoretical model, specifically addressing 
the hypothesis that vascular depression symptoms are an early indicator of a broader pattern of 
decline, and predict mortality indirectly through frailty.  We tested a model temporal change that 
use the intercept-and-slope model (Raudenbush & Bryk, 2002; Raykov & Marcoulides, 2008).  
Mortality risk was modeled using a discrete time-survival term (Singer & Willett, 1993).  
Vascular depression and frailty were modeled using intercept and slope terms for each variable.  
Vascular depression intercept and slope latent variables predicted frailty intercept and slope 
variables, and both intercept and both slope terms were used to predict mortality.  All five terms 
were regressed on self-rated health change, ADLs, IADLs, and age, thereby controlling for the 
influence of variables.   
Longitudinal research with older adults is complicated by high attrition rates, in this case 
reflecting the high rates of mortality and disability.  The conventional strategy of excluding 
respondents with incomplete data systematically underestimates disease severity and incorrectly 
estimates relationships with outcome variables. The full information maximum likelihood 
strategy (FIML; Arbuckle, 1996), was used to account for missing data.  Specifically, auxiliary 
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variables identified as highly predictive of missing data (self-rated health change, ADLs, IADLs, 
and age) were used in both models to improve estimation of missing values (Graham, 2003).  In 
this way, data from all 1,361 respondents with baseline data in the available sample were used, 
regardless of the availability of complete data on vascular depression and frailty symptoms.  
Data were prepared in SPSS V19 and analyses conducted using Mplus.  
Results 
 The final sample included 1,361 respondents with a mean age of 84.12 years (SD=4.10) 
and 10.85 years of education (SD=3.52; Table 5.1).  The sample was predominantly White.  
Attrition was primarily a function of mortality: Of the original 1998 sample, 13.2% had died by 
2000, 30.7% by 2002, 44.6% by 2004, 57.8% by 2006, and 69.7% by 2008.  Frailty rates were 
higher among respondents with higher vascular depression scores at baseline (Table 5.2). 
 The discrete-time survival analysis model (Figure 2) also had good overall fit 
(RMSEA=.05; CFI=.97; X2=234.84, p<.001).  In this model, high vascular depression symptom 
intercept scores significantly predicted attenuated increase in vascular depression scores over the 
course of the study and higher frailty symptom intercept scores.  Control variables were omitted 
from Figure 2 for reasons of visual clarity, but are reported in Table 5.3.  Higher scores on the 
vascular depression symptom intercept term were significantly predicted by greater ADL 
disability (β=.47, p<.001) and greater IADL disability (β=.30, p<.005).  The vascular depression 
symptom slope term was not predicted by any of the control variables.  Higher scores on the 
frailty symptom intercept term were significantly predicted by greater age (β=.23, p<.001) and 
greater ADL disability (β=.32, p<.001).  The frailty symptom slope variable was also not 
predicted by any control variables, though there was a strong trend for older respondents to 
experience greater increase in frailty scores over the course of the study (β=.10, p=.06).  Higher 
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scores on the mortality term, indicating greater mortality risk, were significantly predicted by 
greater age (β=.21, p<.001), more ADL disability (β=.10, p<.001), and greater IADL disability 
(β=.20, p<.001).   
As shown in Figure 5.2, higher vascular depression intercept term scores significantly 
predicted lower vascular depression slope (β=-.35, p=.03), indicating that respondents with few 
vascular depression symptoms at baseline had a greater increase in these symptoms over the 
course of the study.  Higher vascular depression intercept values predicted higher frailty intercept 
scores (β=.26, p<.001), indicating that respondents with more vascular depression symptoms at 
baseline (1998) had more frailty symptoms at the subsequent wave (2000).  Similarly, higher 
vascular depression symptom slope predicted higher frailty symptom slope (β= .10, p=.02), 
indicating that increasing vascular depression symptoms predicted increasing frailty symptoms.  
Respondents with higher frailty scores had attenuated frailty symptom slopes over the course of 
the study (β=-.33, p<.001).  The frailty symptom intercept score significantly predicted mortality 
(β=.02, p=.04), indicating that more frail respondents had higher mortality rates.  The 
relationship between the vascular depression symptom intercept and mortality showed a trend 
toward significance (β=.01; p=.09).  The indirect relationship between the vascular depression 
intercept term and mortality through the frailty intercept term was statistically significant (β=.01, 
p=.04).   
 
Conclusions 
 Our primary finding is the elucidation of a pathway from vascular depression symptoms 
to frailty symptoms to death. In our sample of stroke-free women over the age of 80, vascular 
depression symptoms predicted mortality through frailty symptoms.  These results support the 
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proposed theoretical framework by describing a late-life clinical trajectory characterized by high 
vascular depression and frailty symptoms.  It is important to note that neither high CVB alone 
nor high depression symptoms alone were as good at predicting frailty and/or mortality. Support 
was found for the hypothesis that vascular depression symptoms are prodrome of frailty 
symptoms toward the end of life in older old women. We also found higher rates of vascular 
depression symptoms among elders with higher levels of ADL and IADL disability.  In our 
sample of women over age 80, frailty symptoms were more common with high ADL disability.  
Mortality risk was significantly predicted by age and more ADL and IADL disability. Apart 
from the control variables; age, ADL and IADL disability, and self-reported health change, we 
found a progression from vascular depression symptoms to frailty symptoms to earlier mortality.  
These results support vascular depression theory (Alexopoulos et al., 1997b) and extend it by 
describing the emergence of vascular depression symptoms as an early stage in this chain of 
health decline.  These findings also support work that relates frailty symptoms to mortality (Fried 
et al., 2001).   
One of the biggest questions is whether the emergence of vascular depression symptoms 
are an early or late warning sign of decline. Will interventions at the point of discovering 
vascular depression symptoms avert or delay the onset of frailty and earlier mortality? Our 
results suggest that clinical interventions should be examined.  Most significantly, the role of 
CVB emphasizes the importance of managing vascular risk throughout the lifespan so as to 
lessen its impact in late life. Arguably, the best intervention for the end-of-life trajectory 
described by these results is positive health behaviors across the lifespan. Obesity and resulting 
disorders such as diabetes and metabolic syndrome, for instance, are increasingly prevalent in the 
U.S. population (discussed in Bean, Stewart, & Olbrisch, 2008).  High CVB slowly degrades 
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adaptive resources over many years.  Early intervention may reduce rates of disability, preserve 
psychological health in late life, and delay the onset of frailty, thereby improving quality of life 
for older individuals. 
The second course of investigation suggested by these results relates to slowing the 
transition to frailty, thereby preserving capacity for self-care and quality of life.  Arean and 
colleagues (2010) have extensively researched behavioral interventions for “depression-
dysexecutive syndrome,” which is generally analogous to vascular depression.  Their results 
suggest that this skills-based intervention can improve capacity for self-care and reduce 
symptoms of depression. This intervention’s effect on the transition to frailty has not been 
explicitly studied.   
Our findings’ primary limitation is the use of self-reported medical data.  Future research 
using the HRS data could make use of biomarkers newly available in the 2008 and 2010 data 
releases.  This would also facilitate use of, for instance, blood pressure or glucose response as 
continuous variables that predict development of depression symptoms and frailty.  Our results 
also describe a depression subtype with a clinical course that differs significantly from traditional 
major depressive disorder.  Given the unusually late onset of vascular depression, its relationship 
to medical comorbidities, and other unique characteristics of this depression subtype, 
consideration of a vascular depression specifier for the DSM-IV-TR Major Depressive Disorder 
diagnosis is indicated.  
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APPENDIX A 
 
Table 2.1 
Demographic, independent and dependent statistics for 1,355 participants at baseline (1998)  
 Mean (SD) 
Age 84.8 (4.1) 
Years of Education 10.86 (3.52) 
Ethnic Distribution  
 White 79.5% 
 Black 14.3% 
 Hispanic 5.2% 
 Other 1% 
CVB (total count 0-4) 1.31 (.92) 
TICS 18.14 (6.16) 
CES-D 2.12 (2.00) 
Abbreviations: CVB = Cerebrovascular Burden; TICS = Telephone Interview for Cognitive 
Status; CES-D = Center for Epidemiological Studies Depression Scale 
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 Table 2.2  
Parameter estimates, standard errors, t-values, and p-values associated with the conditional 
LGC model (see Equations (2).  
Predictor Estimate SE t-Value p-Value 
Regression of Initial Depression on 
Age 0.023 0.013 1.775 0.076 
CVB 0.193 0.361 0.534 0.461 
CF -0.083 0.113 -0.738 0.593 
Education -0.155 0.045 -3.467 0.001 
CVB*Education 0.027 0.031 0.868 0.385 
Regression of Rate of Change in Depression on 
Age -0.009 0.007 -1.278 0.201 
CVB 0.256 0.206 1.241 0.215 
CF -0.042 0.058 -0.729 0.466 
Education 0.039 0.024 1.613 0.107 
CVB*Education -0.014 0.017 -0.823 0.410 
CF = cognitive functioning, CVB*Education= interaction of cerebrovascular burden and 
cognitive functioning. 
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Table 2.3  
Parameter estimates, standard errors, t-values, and associated p-values associated with the 
parsimonious conditional LGC model (no interaction term; see note to Table 1 for used variable 
names.   
Predictor Estimate SE t-Value p-Value 
Regression of Initial Depression on 
Age 0.023 0.013 1.730 0.084 
CVB 0.481 0.107 4.513 <0.001 
CF -0.085 0.113 -0.751 0.453 
Education -0.118 0.016 -7.230 <0.001 
Regression of Rate of Change in Depression on 
Age -0.009 0.007 -1.278 0.201 
CVB 0.097 0.055 1.787 0.074 
CF -0.042 0.058 -0.733 0.464 
Education 0.019 0.009 2.217 0.027 
CF = cognitive functioning. 
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Table 2.4 
Percentages of participants with high and low CVB and education with probable depression 
based on CESD score cutoffs of 3 and 5 
     Wave 
     1998 2000 2002 2004 
   N=1,355 N=990 N=737 N=547 
CES-D Cutoff of 3      
 CVB Low 31.3 27.7 28.6 28.1 
 High 42 41.6 40.4 45.1 
 X
2
 16.04*** 20.33*** 10.48*** 15.38*** 
 Years of Educ 0-12 40 35.8 36.1 36.3 
 12+ 23.3 25.5 25.1 25.5 
 X
2 18.38*** 9.64** 8.40** 5.86** 
       
CES-D Cutoff of 5      
 CVB Low 12.2 10.8 10.2 8.8 
 High 18.6 19.3 20.4 22 
 X
2
 10.49** 13.99*** 14.70*** 18.09*** 
 Years of Educ 0-12 16.6 16.4 16.4 13.8 
 12+ 9.5 8.3 7.8 11.1 
  X
2
 10.68*** 12.97*** 9.67** 0.697 
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Table 3.1 
Sample Description at the 2000 wave (baseline).  
Variable Mean SD 
Age 85.63 3.82 
Education 11.03 3.42 
    
CVB 1.03 0.82 
CESD 2.07 1.98 
TICS 18.13 5.86 
BMI 24.40 4.86 
Self-Rated Health 
Change 3.36 0.83 
    
Ethinic Distribution Percentage  
 White 79.7%  
 Black 14.2%  
 Hispanic 5.2%  
 Other 1.1%  
% High CVB 42.2%  
Note. CVB=Number of symptoms comprising cerebrovascular burden (heart disease, diabetes, 
hypertension scored 0-3). CESD=Center for Epidemiological Studies Depression Scale, 
TICS=Telephone Interview for Cognitive Status, BMI=Body Mass Index 
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Table 3.2 
Results of logistic regressions predicting incidence of mortality between 2000 and 2006 and 
between 2000 and 2008.   
  
Predicting death between  
2000 and  2006   
Predicting death between  
2000 and  2008 
Variable B SE Wald 
Exp(B)  
95% CI   B SE Wald 
Exp(B)  
95% CI 
Age 0.15 0.02 55.65 ψ 1.12-1.21  0.15 0.02 46.86 ψ 1.11-1.22 
Education -0.03 0.02 1.61 .93-1.02  -0.03 0.02 1.54 .93-1.02 
BMI -0.07 0.02 17.27 ψ .91-.97  -0.07 0.02 18.76 ψ .90-.96 
CVB 0.46 0.09 26.74 ψ 1.33-1.88  0.56 0.09 36.19 ψ 1.46-2.10 
Self-Rated 
Health 
0.17 0.09 3.21§ .98-1.42  0.15 0.10 2.37 .96-1.41 
2000 CESD 
Score 
0.08 0.04 4.26* 1.00-1.16  0.07 0.04 3.46§ .99-1.16 
‘98-‘00 TICS 
Drop 
0.35 0.21 2.81§ .94-2.12  0.05 0.22 0.06 .69-1.62 
Constant -12.00 1.82 43.44   -11.31 1.97 32.87  
Note. BMI=Body Mass Index. CVB=Cerebrovascular Burden, SR Health Change=Change in 
Self-Rated Health from previous wave, CESD=Center for Epidemiological Studies Depression 
Scale, TICS=Telephone Interview for Cognitive Status.  TICS Drop reflects incidence of decline 
on TICS score greater than 6 points between 1998 and 2000. 
§
p between .05 and .10, *p<.05. ψ p<.001.  df=1 for all comparisons. 
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Table 3.3 
Results of logistic regression analyses predicting death at 2002, 2004, 2006 and 2008 waves 
based on depressive symptoms and incidence of cognitive decline.   
Predicting Death in 2002  Predicting Death in 2004 
 
B SE Wald 
Exp(B) 
95% 
CI   B SE Wald 
Exp(B) 
95% 
CI 
2000 CVB .54 .11 26.83 ψ 
1.40-
2.11  
2002 CVB .43 .12 11.97 ψ 
1.21-
1.97 
2000 CESD .08 .04 3.90* 
1.00-
1.18  
2002 CESD .17 .05 13.71ψ 
1.09-
1.31 
‘98-‘00 
TICS >1SD 
.40 .23 2.92§ 
.94-
2.33  
‘00-‘02 
TICS >1SD 
.76 .27 8.11 + 
1.27-
3.61 
Constant -2.49 .18 183.52 ψ    Constant -2.68 .22 146.83
 ψ   
           
Predicting Death in 2006  Predicting Death in 2008 
 B SE Wald 
Exp(B) 
95% 
CI   B SE Wald 
Exp(B) 
95% 
CI 
2004 CVB .22 .14 2.61 
.95-
1.64  
2006 CVB .44 .17 6.93+ 
1.12-
2.16 
2004 CESD .03 .06 0.29 
.92-
1.15  
2006 CESD .07 .07 1.09 
0.94-
1.22 
‘02-‘04 
TICS >1SD 
.39 .34 1.36 
.77-
2.85  
‘04-‘06 
TICS >1SD 
1.12 .43 6.86 + 
1.33-
7.06 
Constant -1.79 .22 64.51    Constant -2.15 .30 50.13
 ψ   
Note. CVB=Cerebrovascular Burden. CESD=Center for Epidemiological Studies Depression 
Scale. TICS=Telephone Interview for Cognitive Status. TICS Drop reflects incidence of decline 
on TICS score greater than 6 points between waves as indicated. 
§
p=.088, *p<.05. + p<.01, ψ p<.001. df=1 for all comparisons. 
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Table 4.1 
Description of Sample 
    
2000 
(N=984) 
2004 
(N=459) 
Variable Mean (SD) Mean (SD) 
Age 
85.62 
(3.82) 84.53 (3.03) 
Education 
11.02 
(3.44) 11.24 (3.13) 
ADLs .64 (1.12) 0.24 (0.69) 
IADLs .21 (.55) 0.10 (0.38) 
2000 CESD 2.07 (1.98) 1.55 (1.70) 
    
  % of Samp % of Samp 
Ethnicity   
 White 79.6 80.2 
 Black 14.3 12.4 
 Latina 5.3 6.1 
 Other 1 1.5 
CV Risk Factors   
 Hypertension 57.6 52.9 
 Diabetes 11.5 7 
 Cardiac 34.8 25.1 
 Smoking 34.9 34.9 
Non-CV Health   
 Arthritis 69.6 59.3 
 Pulmonary 7.2 4.8 
 Cancer 14.8 14.6 
2000 CVB (% High) 42.2 33.3 
2000 CESD (% High) 32.8 22 
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Table 4.2 
Prevalence in 2000 and incidence in 2004 of frailty among respondents without high CVB or 
probable depression (CESD score ≥3), respondents with high CVB or probable depression, and 
respondents with both high CVB and probable depression . 
 
2000 
Prevalence 
 2004 
Incidence 
  n % Frail  n % Frail 
Low CVB, Low CESD 413 20.1%  248 25.0% 
High CVB or High CESD 404 34.9%  168 35.7% 
High CVB, High CESD 86 51.5%  43 55.8% 
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Table 4.3 
Results of logistic regression predicting frailty in 2000.  N=984. 
 Block 1  Block 2 
 B S.E. Wald 95% CI  B S.E. Wald 95% CI 
Age .06 .02 9.11** 1.02-1.11  .06 .02 9.52** 1.02-1.11 
Education .02 .02 0.97 .98-1.07  .03 .02 2.14 .99-1.08 
ADLs .64 .08 57.89*** 1.61-2.24  .60 .09 49.61*** 1.54-2.15 
IADLs -.02 .16 0.02 .72-1.33  -.03 .16 0.03 .71-1.33 
Arthritis 1.09 .20 30.47*** 2.03-4.40  1.05 .20 28.18*** 1.94-4.23 
Pulmonary .41 .28 2.16 .87-2.62  .41 .28 2.08 .86-2.61 
Cancer .34 .21 2.62 .93-2.14  .33 .22 2.33 .91-2.12 
S-R Hlth Δ .46 .10 20.91*** 1.30-1.93  .39 .10 14.58*** 1.21-1.80 
Vascular Dep.      .41 .11 13.26*** 1.21-1.88 
Constant -9.26 1.84 25.25***   -9.53 1.85 26.68***  
*p≤.05; **p≤.01; ***p≤.001; S-R Hlth Δ=Self-rated health change;ADLs=Activities of Daily 
Living; IADLs=Instrumental Activities of Daily Living; Vascular Depression – respondents with 
neither high CVB or CESD scores≥3 scored 0, respondents with high CVB or CESD scores≥3 
scored 1, respondents with both high CVB and CESD scores≥3 scored 2. 
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Table 4.4 
Results of logistic regression predicting frailty in 2004. N=459. 
 Block 1  Block 2 
  B S.E. Wald 95% CI  B S.E. Wald 95% CI 
Age .05 .03 1.96 .98-1.12  .05 .03 2.03 .98-1.12 
Education -.03 .03 .75 .91-1.04  -.02 .03 .43 .91-1.05 
ADLs .50 8.00 7.85** 1.16-2.36  .49 .18 7.21** 1.14-2.32 
IADLs .45 .32 1.95 .83-2.93  .43 .32 1.85 .83-2.86 
Arthritis .38 .22 2.99 .95-2.25  .33 .22 2.14 .90-2.14 
Pulmonary -.74 .55 1.76 .16-1.42  -.57 .56 1.04 .19-1.69 
Cancer .23 .29 .63 .71-2.23  .19 .30 .42 .68-2.16 
S-R Hlth Δ .69 .17 15.89*** 1.42-2.81  .65 .18 13.53*** 1.35-2.70 
Vascular Dep.      .49 .16 9.12** 1.19-2.24 
Constant -7.08 2.99 5.62*   -7.35 3.01 5.96*  
*p≤.05; **p≤.01; ***p≤.001; S-R HlthΔ=Self-rated health change; ADLs=Activities of Daily 
Living; IADLs=Instrumental Activities of Daily Living; Vascular Depression – respondents with 
neither high CVB or CESD scores≥3 scored 0, respondents with high CVB or CESD scores≥3 
scored 1, respondents with both high CVB and CESD scores≥3 scored 2. 
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Table 5.1 
Description of the sample at baseline (1998) 
Variable Mean (SD) 
Age  84.12 (4.10) 
Years of Education 10.85 (3.52) 
CVB  1.31 (.92) 
ADLs  .63 (1.16) 
IADLs .23 (.59) 
Self-Rated Health Change .23 (1.10) 
  
 
% of Sample 
Ethnic Distribution  
 White 79.7 
 Black 14.3 
 Hispanic 5.2 
 Other 0.8 
Medical Diagnoses  
 Hypertension 53.8 
 Diabetes 11.3 
 Cardiac Disease 30.9 
 Arthritis 64.8 
 
Pulmonary 
Disease 7.2 
  Cancer 13.8 
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Table 5.2 
Frequencies and mean (SD) frailty scores by Wave 4 VD score 
Wave 4 
VD Score 
  Mean (SD) Frailty Score 
Freq. Description Wave 5 Wave 7 Wave 9 
1 303 Very Healthy 1.58 (1.34) 1.88 (1.27) 2.13 (1.26) 
2 273 Healthy 1.18 (1.20) 2.06 (1.15) 2.48 (1.05) 
3 562 High CVB or  
Probable Depression 
2.05 (1.28) 2.31 (1.19) 2.52 (1.07) 
4 121 Vascular Depression, 
Mild 
2.52 (1.19) 2.60 (1.16) 1.77 (1.01) 
5 96 Vascular Depression, 
Moderate-Severe 
2.48 (1.30) 2.82 (1.14) 3.08 (1.31) 
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Table 5.3 
Unstandardized regression coefficients for control variables (age, self-rated health change, 
ADLs and IADLs) on vascular depression intercept and slope, frailty intercept and slope, and 
mortality 
Latent Var. Control Var. β S.E 
VD-Int.    
 Age -0.04 0.05 
 Self-Rated Health Δ -0.10 0.05 
 ADLs 0.47*** 0.07 
 IADLs 0.30** 0.11 
VD-Slope    
 Age 0.01 0.12 
 Self-Rated Health Δ 0.16 0.12 
 ADLs -0.02 0.14 
 IADLs 0.46 0.37 
Frailty-Int    
 Age 0.23*** 0.04 
 Self-Rated Health Δ 0.02 0.04 
 ADLs 0.32*** 0.06 
 IADLs -0.07 0.10 
Frailty-Slope    
 Age 0.10 0.05 
 Self-Rated Health Δ -0.06 0.04 
 ADLs -0.06 0.08 
 IADLs 0.17 0.17 
Mortality    
 Age 0.21*** 0.02 
 Self-Rated Health Δ 0.00 0.02 
 ADLs 0.10*** 0.02 
  IADLs 0.20*** 0.04 
*p<.05; **p<.01; ***p<.001 
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APPENDIX B 
 
Figure 1.1 
Conceptual model 
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Figure 2.1 
Plotted growth curves depicting CES-D score over time for the low CVB/low education, low 
CVB/high education, and high education/low CVB groups.  
 
Note: For reasons of visual presentation, the education variable was dichotomized for this figure 
(Low Ed: 12 years or less, High Ed: more than 12 years). 
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Figure 4.1 
Specification of Vascular Depression variable based on CESD score and number of 
cerebrovascular risk factors reported at wave 4 
CESD 
Score Wave 4 CVB Total 
 0 1 2 3 4  
0 86 152 77 25 3 343 
1 65 135 74 27 3 304 
2 43 95 68 22 1 229 
3 26 78 53 16 2 175 
4 19 37 34 14 2 106 
5 15 31 28 8 2 84 
6 5 26 23 13 0 67 
7 3 16 10 5 0 34 
8 0 6 4 3 0 13 
Total 262 576 371 133 13 1355 
  
VD Score = 3 
VD Score = 4 
VD Score = 5 
VD Score = 3 
VD Score = 2 
VD Score = 1 
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Figure 4.2 
Structural model depicting slope and intercept terms for vascular depression symptoms and 
frailty symptoms, and a discrete-time survival term reflecting mortality risk predicted by all four 
factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
+
p<.10; *p<.05;  V=Vascular Depression.  F=Frailty.  M=Mortailty. 
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Women over the age of 80 represent a rapidly growing demographic group.  While older 
women live longer than men, they do so with more years of disability and frailty.  The 
emergence of geriatric disorders such as vascular disease, depression, frailty and cognitive 
decline in the aging US population place additional strain and expense on the already over-
burdened public health care system.  Meanwhile, integrated models of care are associated with 
preserved functional independence, reduced medical costs, and greater satisfaction for both 
health care providers and patients.  Implementation of integrated care demands process-models 
of disease that contextualize symptoms within broader patterns of decline. This dissertation 
proposes a model representing a hypothesized late-life clinical trajectory following from high 
cerebrovascular burden.  The hypothesized trajectory includes higher rates of depression (of 
vascular origin), cognitive decline, frailty and shortened remaining lifespan.  Different facets of 
this model are tested in the four studies that comprise this dissertation.   
The sample was drawn from the Health and Retirement Study; a longitudinal, 
demographically-representative data sample of older adults in the United States.  The sub-sample 
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used in this dissertation included 1,368 stroke-free women over the age of 80 at baseline (1998).  
This sub-sample was followed for 10 years. 
The first study tested the hypotheses that high CVB predicts greater depression 
symptoms, and that brain reserve (i.e.: education) protects elders from developing depression 
symptoms.  A latent growth curve was used to identify differences in depression at baseline and 
over time based on CVB, cognitive functioning, education and age.  Results indicate that at any 
level of CVB, older women with more education experienced fewer depression symptoms.  
Results support brain reserve theory and the vascular depression hypothesis.  These results 
suggest that having greater education may postpone development of clinically-significant 
depressive symptoms resulting from high CVB, thereby preserving mood in late life. 
The second study tested the hypothesis that variables representing the three domains of 
Rowe and Kahn’s Healthy Aging framework predict longevity in this sample of stroke-free 
women over the age of 80.  The “avoidance of disease” domain was characterized in this paper 
as CVB - chronic comorbidites that slowly erode adaptive functioning over many years. The 
“sustained engagement” criteria was conceptualized as depression, and deficits in the 
“preservation of cognitive and physical functioning ” domain were identified as rapid cognitive 
decline.  We found that at most waves (2002, 2004, 2006) mortality was predicted by CVB, 
depressive symptoms and cognitive drop measured 2 years prior.  CVB and depressive 
symptoms at the 2000 wave predicted mortality at 6 and 8-years.  Older women with the greatest 
longevity had low CVB, robust cognitive functioning and few depression symptoms, supporting 
successful aging theory and terminal cognitive drop.   
The third study tested the hypothesis that vascular depression is a prodrome for frailty.  
At baseline, the prevalence of frailty was 31.5%.  Over a 4-years the incidence of frailty was 
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31.8%.  After controlling for age, education, ADL and IADL functioning, arthritis, pulmonary 
disorders, cancer, and self-rated health, vascular depression significantly predicted new cases of 
frailty. These findings suggest that vascular depression is a prodrome for frailty. 
The fourth study tested the proposed model using structural modeling.  The model 
demonstrated good overall fit and a significant indirect pathway from vascular depression to 
mortality through frailty was identified.  Results support the proposed theoretical framework and 
suggest that vascular depression symptoms are associated with a clinical trajectory including 
more frailty symptoms and shorted remaining lifespan.  This finding supports integrated care for 
geriatric patients and suggests specific targets for intervention with older patients experiencing 
vascular depression symptoms.  
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